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 Our aim was to understand mechanisms responsible for excessive electrolyte loss 
in the sweat gland and the potential impact on fluid balance during exercise in heat stress 
conditions. Human physiological testing under exercise/heat stress and 
immunofluorescence staining of sweat glands from skin biopsies were compared between 
healthy individuals (with normal and high sweat sodium concentration) and with cystic 
fibrosis patients (CF), who exhibit excessively salty sweat due to a defect of Cl- channel 
cystic fibrosis transmembrane conductance regulator (CFTR). Three novel findings are 
presented. First, excessively salty sweat may be associated with reduced expression of 
CFTR in the sweat gland reabsorptive duct of healthy individuals in addition to in those 
with cystic fibrosis (CF); however, although a link to a CF gene mutation in healthy 
individuals with high sweat sodium was not demonstrated, the possibility of an 
undetected CFTR mutation or polymorphism remains to be investigated as an underlying 
mechanism. Two, CF and healthy individuals with excessively salty sweat respond to 
moderate dehydration (3% body weight loss during exercise) with an attenuated rise in 
serum osmolality, greater relative loss in plasma volume, but similar perceived thirst 
compared to healthy individuals with “normal” sweat sodium. However, individuals with 
CF respond to rehydration (presentation of hypotonic beverage following dehydration) by 
drinking less ad libitum in response to reduced serum sodium chloride concentration, 
suggesting that thirst-guided fluid and electrolyte replacement may be more appropriate 
for CF patients rather than restoring 100% of sweat loss following dehydration as is often 






1.1  Variability in the NaCl Content of Human Eccrine Sweat 
There is considerable disagreement in values reported for the electrolyte 
composition of human sweat 1, particularly in the electrolyte sodium (Na+) for which the 
concentration can vary greatly within and between individuals 2-4.  Across studies there is 
disparity in reported sweat electrolytes with values for mean sweat sodium concentration 
([Na+]) from 30 mmol/L 5 to as high as 90 mmol/L 6 for healthy subjects. Discrepancies 
in sweat composition between studies can be related to differences in sweat stimulation 
method 7-11; rate of sweating elicited 12 13; acclimation status of subjects 14-17; anatomic 
location 8 18;  and technique used (gauze pad 1, Brisson pouch 19 20, whole body washdown 
21 22, arm bag 23, or ventilated capsule 24) for sweat collection. Variability in sweat 
composition among subjects within a single study, where such factors are controlled, is 
still commonly high. This is particularly true for [Na+] where reported mean values for 
typical subject pool are typically accompanied by large SDs (e.g. + 10-20 mmol/L) with 
coefficient of variation ranging from 40 to 60%.  
 Electrolytes in the extracellular fluid (ECF), and specifically in the vascular space 
of the ECF, are maintained in a fairly tight physiological range in humans. It is puzzling, 
therefore, that humans are also known to exhibit large variability in Na+ loss during both 
thermal- 3 4 9 25 26 and pharmacologically 2 9 27 -induced eccrine sweating compared to 
other electrolytes such as potassium (K+). Sweat electrolyte composition at a given sweat 
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rate is not believed to be influenced by gender 28 or age 29.  The impact of diet, 
specifically sodium ingestion, however, is debated 30-32. Sweat composition can be 
acutely altered by dehydration. Healthy subjects exercising in the heat exhibited higher 
mean sweat [Na+] and chloride concentration ([Cl-]) during dehydration compared to 
when hydration was maintained via fluid ingestion (euhydration) 6.  It is also well-
documented that heat acclimation reduces sweat electrolyte loss by producing a more 
copious and dilute sweat 14-17 33 ; however, even when controlling for acclimation status, 
some individuals continue to excrete higher concentrations of sweat NaCl for reasons that 
have not yet been fully identified or understood. The underlying mechanisms responsible 
for this sweat [NaCl] variability might be attributed to individual differences in sweat 
duct absorption of electrolytes.  
 
1.2  Eccrine Sweat Gland Physiology 
 Human skin adaptations are the result of physical modifications to climate and 
environment changes over the last 4 to 7 million years 34. In addition to loss of hair and 
skin pigmentation, the human eccrine sweat gland is thought to have been a key 
evolutionary adaptation for humans to become superior predators 35. Unlike humans and 
horses, other mammals are not capable of copious sweating in response to a rise in body 
temperature and, coincidentally, are also unable to perform sustained running 34 36.  
Sweating occurs through two types of glands in mammals: apocrine and eccrine sweat 
glands.  Humans use primarily eccrine sweating while other mammals, including horses, 
exhibit apocrine sweating 34 37. Apocrine sweating is considered to be primitive, the 
quantity is small in most mammals (except in horses) making it less effective for 
dissipating heat 34. The human body contains typically 2 to 4 million eccrine sweat glands 
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distributed over most body surfaces. The density of sweat glands varies by region, for 
instance, there are approximately ~ 64 per square cm on the back but two to three times 
as many over the forearm and forehead 38.  
The eccrine sweat gland is composed of two morphologically and functionally 
distinct components, a secretory coil and a reabsorptive duct.  The secretory coil is 
responsible for the formation and secretion of an isotonic fluid when stimulated via 
cholinergic or adrenergic receptors 38. Originally thought to operate under the pump leak 
model 39, it is now understood that the Na-K-2Cl cotransport model 40 better explains the 
mechanism of eccrine sweat secretion 38 41 (Fig 1.1). Upon cholinergic or adrenergic 
stimulation, extracellular calcium (Ca2+) enters the secretory cell 42 and opens cAMP 
activated Cl- channels (cystic fibrosis transmembrane conductance regulator, CFTR) in 
the luminal membrane, as well as Ca2+ sensitive K+ channels in the basolateral membrane 
43 44. This results in the electrically-neutral KCl loss from the cytoplasm and the decrease 
of cell volume. Loss of KCl produces a favorable chemical potential gradient for the 
influx of K+ and Cl+ from the interstitial medium thru NaK2Cl co-transporters45. The Na+ 
carried into the cell by the cotransporters is then pumped out across the basolateral cell 
membrane by Na+K+ATPase. Transport of Cl- into the lumen produces lumen negative 
transepithelial potential and Na+ enters the lumen from the interstitial fluid through a 
paracellular route.  Water enters the lumen as needed to balance the Na+ and Cl- 38.  
 The iso-osmotic initial fluid, or ‘primary’ sweat produced by the secretory 
portion of the gland is approximately isotonic with plasma, containing NaCl 
concentrations approximately equal to blood levels 46.  The primary sweat travels through 
the coil and enters the lumen of the two-cell thick reabsorptive duct 38. In the duct, NaCl 
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in the primary sweat is partially reabsorbed by passive transport of Na+ and Cl- into the 
ductal cell via apical membrane channels CFTR and epithelial sodium channel (ENaC) 47-






























Fig 1.1: Schematic of membrane transport proteins involved in the Na-K-2Cl model of 
sweat secretion in a secretory coil cell.   
 
 
gradients and K+ is passively transported out basolateral K+ channels 41.  In addition, a 
proton pump present on the apical membrane of the luminal cell is suggested to be 
responsible for acidifying sweat as it passes through the lumen 50 51.  More recently, a 
sodium hydrogen exchanger (NHE1) was identified on the basolateral membranes and is 
likely responsible for intracellular pH and cell volume regulation as it is in other tissues 51 
52.  Modification of primary sweat in the duct produces a hypotonic liquid for excretion at 
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the skin surface as ‘final’ sweat 38.  The hypotonicity of excreted sweat can vary greatly 
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sweat exits skin 
[Na+ ] = ~ 43 mmol/L
 
 
Fig 1.2: Schematic of membrane transport proteins involved in ductal cell modification 
of primary iso-osmotic secreted sweat into hypotonic final sweat by reabsorption of Na- 
and Cl-. Only the inner ductal cell is represented in the schematic for simplicity.  
 
 
1.3  Cystic Fibrosis Sweat 
Individuals with the inherited autosomal recessive disease cystic fibrosis (CF) 
excrete sweat with a three to five times higher [NaCl] than typical 53-55. The primary 
sweat is not different in CF; it is failure of NaCl reabsorption in the CF sweat duct 
(calculated to be approximately 20% of normal based on the Thaysen-Schwartz model of 
isotonic secretion) 56 that results in the excessively salty sweat of CF patients 57. The CF 
sweat duct is defective in NaCl absorption due to an absence or malfunction of the 
mutated CF gene product CFTR in the apical and basolateral membranes 12 58-60.  No 
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studies have attempted to demonstrate a relationship between sweat duct membrane 
transport protein expression/activity and extent of sweat electrolyte loss during 
physiological thermoregulatory sweating in CF compared to individuals without disease. 
A whole-cell patch clamp study comparing normal and CF sweat gland cells 61 found no 
difference in channel types and proportions however their data is from secretory not 
ductal cells. This is an important distinction because it has been known for some time that 
“primary” sweat (entering the duct after exiting the secretory portion of the gland) is 
isotonic with respect to ECF and any decrease in [electrolyte] in the excreted sweat 
compared to ECF reflects the absorptive properties of the sweat duct 57. The study of 
sweat from isolated microperfused sweat duct segments 62, and from pharmacologically-
induced local sweat tests 27 54 63, have helped characterize the CF defect. However, 
pharmacologically-induced sweating only reflects one aspect of sweat gland function. 
Physiological in situ sweating is controlled by multiple innervations to the sweat gland 
under the influence of multiple endogenous agonists 38.  For example, thermally-induced 
sweat contains a significantly lower [K+] when compared to both pilocarpine- 8 , and 
methacholine- 64 induced sweat and could reflect endogenous agonist activity on K+ 
channel activity. This is in parallel with new evidence suggesting that CFTR activity in 
the sweat duct may be regulated by relative kinase and phosphatase activity in response 
to changes in relative intracellular concentrations of K+ and Na+  49. Furthermore, exercise 
is known to induce greater increases in blood flow 65 and periglandular region 
temperature 66, as well as higher concentrations of circulating adrenergic hormones that 
can serve as co-factors in the sudorific response 38, all of which may contribute to the 
differences between pharmacologically- , passive heating- , and exercise-induced 
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sweating 11. Therefore, while elevated sweat electrolytes in pharmacologically-induced 
CF sweat is well-documented, electrolyte composition of in situ sweating (i.e. as 
encountered in the context of exercise) remains to be elucidated for this population.  
Some healthy individuals without CF also exhibit sweat [Na+ ] approaching that 
of CF 64.  The explanation for this is unknown and a genetic link to CF has been theorized 
67, but never directly investigated in individuals with excessively salty sweat.  In a study 
comparing CF heterozygote and homozygote newborns (n= >700) with the CFTR 
mutation ΔF508 and non-CF newborns, heterozygotes had significantly higher 
pilocarpine-induced sweat [Na+] and [Cl-] than the non-carrier newborns 68. In a more 
recent study, healthy individuals that were CF heterozygotes (n >500), were shown to 
have a lower rate of increase in systolic blood pressure with age; and the subjects with the 
lowest blood pressures were heterozygotes with the highest pilocarpine-induced sweat 
[Na+] and [Cl-] 69.   
It is not known if a CF mutation can explain differences in sweat [NaCl] in 
healthy individuals (e.g. those with high and ‘typical’ [NaCl]). A recent review 70 
suggested that perhaps certain unidentified populations are at risk for the development of 
exercise-associated hyponatremia (blood [Na+] < 135 mmol/L), such as those without 
disease but heterozygotes carrying variants of the CFTR gene. It was suggested that 
future research addressing this would be helpful in determining if this genetic basis could 
explain why some individuals develop low serum Na+ levels during prolonged activity in 
the heat 70.  To our knowledge, it has not been investigated whether apparently healthy 
individuals who exhibit excessively salty sweat (heretofore referred to as ‘salty 
sweaters’) are carriers of a CF gene mutation. Moreover, the quantity and function of 
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CFTR and ENaC in these non-CF ‘salty sweaters’ have not been examined and compared 
to those individuals with normal sweat [NaCl] or CF patients. The first Aim of this 
research was to investigate if a cellular mechanism similar to that in CF disease (i.e. 
decreased channel number) also explains heterogeneity in sweat [NaCl] between 
“healthy” individuals. Therefore, with an original investigation of ductal electrolyte 
transport channel expression and the incidence of CF mutations in apparently healthy 
‘salty sweaters’ compared to those with ‘average’ sweat [NaCl], the first major aim of 
this dissertation research tested the hypothesis that a mechanism (similar to that in CF 
disease) explains the variance in sweat NaCl loss in human eccrine sweating. The 
findings related to this Aim are detailed primarily in chapter 2 of this thesis.  
 
1.4  Impact of Sweat NaCl Loss on Physiological Responses to  
Exercise and Dehydration 
As discussed above, some individuals without CF excrete sweat containing high 
[NaCl], with values approaching that of CF 64. It is not known if other physiological 
responses such as blood osmolality and blood electrolytes during prolonged exercise are 
affected in ‘salty sweaters’ compared to their normal-to-low sweat NaCl counterparts. 
Furthermore, it is not known if the body water deficit commonly incurred during 
prolonged exercise in the heat differentially affects thirst drive and thermoregulation in 
salty sweaters. There is a strong positive cause-effect relationship between the sensation 
of thirst and plasma osmolality 71-74. Approximately 0.8% body weight loss and 1-2% 
increase in plasma osmolality represent the hypovolemic, and hyperosmotic thresholds 
for the stimulation of thirst in humans, respectively 73 75-77. The hyperosmotic thirst 
mechanism (in response to plasma osmolality increases) is thought to have greater 
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sensitivity than the hypovolemic thirst mechanism (loss of blood volume) 71 75 78.  As 
plasma osmolality increases, plasma vasopressin (AVP) is released, mediated by 
signaling from osmoreceptors of the preoptic anterior hypothalamus. In response to rise 
in plasma osmotic pressure (via either fluid loss or solute concentration increase), fluid 
shifts down a concentration gradient out of cells (cell dehydration) to maintain fluid 
volume in the vascular space 79 80. It is thought that this cell dehydration, in response to a 
rise in extracellular osmotic concentration, provides the strong stimulus for thirst because 
the activated volume-depleted osmoreceptor cell signals for increased release of AVP 71 
81 82.  
No study has examined if blood osmolality and blood [Na+] are lower and alter 
thirst drive in CF and healthy ‘salty sweaters’ compared to those with typical sweat NaCl 
loss at the same relative level of dehydration during exercise in the heat.  One study 83 
that compared thirst-guided drinking behavior of CF to non-CF children during a three 
hour intermittent exercise session (20 min cycling at 45%VO2max with 25 min rest 
periods) found that  CF children drank significantly less than controls and subsequently 
lost twice as much body weight. Unfortunately blood osmolality measures were taken 
only at the end of the three hour session and reflected not only the electrolyte loss but 
also the consumption of differing amounts of water. Therefore, while the authors 
postulated that the high NaCl loss in CF prevented the sweating-induced hyperosmolality 
of body fluids and thus deprived the CF children of a thirst trigger, they conceded that 
without serial blood samples during the protocol, they could not confirm  the greater 
NaCl loss was accompanied by lower serum osmolality throughout  exercise  83. Clearly, 
further research is required to understand the impact of high sweat NaCl on physiological 
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responses regulating fluid and electrolyte homeostasis during prolonged exercise. 
Therefore, in addition to investigating the mechanisms related to high sweat [NaCl], the 
present dissertation work included experiments of human physiological testing in order to 
explore questions related to implications. Findings and conclusions related to 
physiological testing are detailed primarily in chapter 3 of this thesis.  
 
1.4.1  To Rely or Not to Rely on Thirst 
 Since first recognized in 1965, many researchers have confirmed that a lag in the 
thirst mechanism can lead to inadequate body fluid homeostasis and impair 
thermoregulation as well as exercise performance 84-87. Montain et al. 88 reported 
impaired thermoregulatory capacity during exercise in the heat with dehydration to 3% 
and 5% body weight loss as compared to euhydration trials.  With lag in the thirst 
mechanism potentially contributing to inadequate hydration during prolonged exercise in 
the heat, regimented or ‘programmed’ drinking according to a formula based on sweat 
losses has been recommended and published by expert organizations to ensure safety and 
improve performance in sport 4 84.  It is argued by some that moderate dehydration during 
exercise is actually preferable such that reliance upon thirst to dictate fluid intake 
prevents the problem of water intoxication by regimented, overconsumption of hypotonic 
fluids 89-92. Most cases of exercise-induced hyponatremia (Fig 1.3) (serum Na+ < 135 
mmol/L) (Fig. 3) are attributed to overconsumption of  hypotonic fluid (water, low 
sodium beverages), replacement in excess of fluid loss, and is indicated by post-event 
weight gain 93. Whether thirst-guided drinking may sufficiently maintain fluid balance 
during prolonged physical activity in the heat depends on the accuracy of the thirst drive 
and regulatory inputs to thirst such as blood osmolality. A second Aim of this research 
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investigated if thirst perception appropriately reflects body water loss in individuals with 
high sweat NaCl loss. These findings are presented in chapter 3 of this thesis.  
 
 
Fig. 1.3:  Model of Contributing Factors to Exercise-Induced Hyponatremia 
 
 
1.4.2  Impact of Sweat NaCl Loss on Electrolyte Balance 
 While not as common, hyponatremia may also occur in conjunction with 
dehydration, particularly in longer, ultraendurance events 26 70 94. This ‘hypovolemic 
hyponatremia’ is possible presumably from excessive salt depletion via sweating and not 
from overdrinking, according to a recently-developed quantitative model (Fig. 1.3) 26.  It 
is believed that a large sweat NaCl loss during exercise presents a greater risk for the 
development of hyponatremia during prolonged activity in the heat 70 95 96.  Mathematic 
predictions for change in serum [electrolytes] with progressive dehydration have not been 
 
Hyponatremia 
Modified from Montain et al. Exer. Sport Sci. Rev. 2001 
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validated in a field or laboratory setting using individuals at extreme ends of the sweat 
[NaCl] continuum. Therefore, a secondary goal of the dissertation work was to evaluate 
implications related to mathematically-predicted and actual serum [electrolytes] in 
individuals with high vs. ‘typical’ sweat [NaCl] and will be discussed in chapter 4 of this 
thesis.       
 
1.4.3  Cystic Fibrosis and Exercise in the Heat 
 This dissertation’s investigation into implications of high sweat [NaCl] loss was, 
for the most part, novel for the healthy and physically-fit individuals studied. However, 
research into differential responses related to fluid and electrolyte balance as a result of 
salty sweat was almost entirely unexplored territory for the CF subjects included in this 
work. Exercise physiology in the CF population has been an understandably low research 
priority given the average life expectancy for a CF patient, up until 1990, was not beyond 
the teenage years. Management of respiratory and digestive sequelae has greatly 
improved for CF and not only has the average life expectancy nearly doubled since 1990, 
CF are participating in recreational and competitive sports in increasing numbers.  Some 
of the unique responses of CF are presented in chapter 3 of this thesis. It is hoped that 
these findings may contribute to the development of recommendations for CF, as well as 
non-CF exercisers with excessive sweat NaCl loss, to more safely and comfortably 




REDUCED EXPRESSION OF CFTR IN SWEAT DUCTS OF 
HEALTHY INDIVIDUALS AND CYSTIC FIBROSIS PATIENTS 
WITH HIGH SWEAT SODIUM  
  
2.1. Abstract 
Humans exhibit large variability in sodium chloride loss through eccrine 
sweating. In an effort to understand the underlying mechanisms responsible for 
heterogeneity of human NaCl losses in sweat during exercise, we investigated the 
relationship between sweat duct membrane transport protein expression and sweat 
electrolyte concentration.  We hypothesized that CFTR expression would be decreased in 
healthy individuals with high sweat sodium concentration ([Na+]) in a mechanism similar 
to CF. Skin biopsies and sweat samples were obtained from physically-active, healthy 
young adults and from six physically-active patients with CF. Half of the non-CF subjects 
were individuals identified to excrete sweat with high sweat [Na+], ‘salty sweaters’.  CF 
and healthy subjects performed cycling ergometry in the heat to obtain sweat samples for 
electrolyte measurement. Immunofluorescent staining for the chloride channel CFTR, 
and for the sodium channel alpha-ENaC, was performed on cryosections of skin biopsies. 
Ductal and lumenal CFTR and ENaC fluorescence was quantified by a blinded 
investigator. Immunofluorescent staining of sweat glands revealed significantly lower 
luminal membrane CFTR in ducts of non-CF ‘salty sweaters’ (p<0.05) and CF (p<0.005) 
when compared to Control. Epithelial Na+ Channel (ENaC) staining was similar among 
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the three groups.  Genetic testing of healthy subjects to investigate a possible CF gene 
mutation underlying ductal Cl- channel deficiency did not result in any CF heterozygotes 
(carriers) within non-CF groups. Availability of CFTR for facilitation of electrolyte 
transport across the ductal membrane may contribute to the high physiological variability 
known for eccrine sweat NaCl across apparently healthy humans. Yet, we found no direct 
evidence that lower CFTR in healthy individuals who excrete excess sodium chloride had 
a relationship to any of the known, common disease-causing CF gene mutations. 
2.2. Background 
2.2.1.  NaCl Reabsorption in the Eccrine Sweat Gland 
Fluid excreted by the sweat gland is the work of two morphologically and 
functionally distinct organ components, a secretory coil and a reabsorptive duct. In a two-
step process common to all mammalian fluid secretory systems, a primary isotonic fluid 
secretion (i.e. similar in electrolyte concentration to blood) is modified as it travels 
through the lumen of the reabsorptive duct and, in humans, results in a final sweat that is 
hypotonic to the plasma 12 38.  Despite controlling for factors known to influence 
measured sweat concentration such as acclimation status 14-17 and sweat stimulation 8 10 11 
and collection 21-23 technique, the diluteness of this final excreted sweat can vary greatly 
between individuals 1-4. Since primary sweat is always isotonic to the plasma 97 98, 
glandular mechanisms underlying this inter-individual ‘physiological’ variability are 
presumably due to differences in sweat duct electrolyte reabsorption 38.  A principal 
source of Cl- conductance in the reabsorption process 99, the cystic fibrosis 
transmembrane conductance regulator (CFTR) is highly expressed 58 59 and constitutively 
active 48 in the apical membrane of the normal sweat duct. CFTR activity regulates an 
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epithelial sodium channel (ENaC) 100, the only channel for luminal Na+ entry into the 
ductal cell.   
Cystic fibrosis (CF) is an inherited autosomal recessive disease of faulty 
electrolyte transport due to insufficient CFTR activity that results in a secondary loss of 
CFTR-dependent ENaC conductance. In the sweat gland, CFTR malfunction results in 
excretion of sweat with a three to five times higher sodium chloride concentration [NaCl] 
than typical 53-55. The mechanism for and extent of insufficient CFTR activity is 
mutation-specific although the relationship between genotype and phenotype and sweat 
[NaCl] is debated 101-104. The secreted primary sweat in CF is not different than in non-
CF; it is failure of NaCl reabsorption in the sweat duct (calculated to be approximately 
20% of normal based on the Thaysen/Schwartz model of isotonic secretion 56) that results 
in the excessively salty sweat of patients 57. 
Studies of the composition of pharmacologically- and thermally-induced sweat 
have identified that some non-CF subjects have sweat Na+ levels that approach that of CF 
64. It is possible that reduced expression of ductal transport proteins CFTR and ENaC 
mechanistically underlies these apparently-healthy ‘salty sweaters’,  potentially linked to 
a genetic cause such as a heterozygous CF mutation 70. A mutation of the CF gene occurs 
with high frequency in man, ~1 in 25 Caucasians of European descent 105 106.  Some 
reports have shown a greater incidence of heterozygocity for a CF mutation in non-CF 
persons prone to chronic CF-like conditions such as idiopathic pancreatitis 107 108, 
bronchiectasis, nontuberculous mycobacterial infections 109, and chronic rhinosinusitis 
110-112. Furthermore, sweat induction by beta-adrenergic stimulation (a secondary method 
of sweat gland stimulation 11 38) cannot occur in CF homozygotes 113 and is not as 
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effective in CF heterozygotes as compared to non- carriers 114 115.  Differences in sweat 
electrolyte composition of CF heterozygotes as compared to non-carriers are debated, 
mostly due to difficulty sorting out the major confounding factor of sweat rate 12. CF 
carriers have pilocarpine-induced sweat Cl- and Na+ levels that are significantly higher 
than non-carriers (2-5 times normal has been reported) but lower than CF homozygotes 
116. In pilocarpine-induced sweat tests performed on CF gene carriers and non-carriers 
with chronic pancreatitis (n=134), a step-wise increase in sweat [Na+] and [Cl-] was 
reported where non-carriers had the lowest concentrations and carriers had the highest 
concentrations 108.  Thus, it is plausible that there exists a correlation between apparently-
healthy individuals with greater NaCl loss in sweat and a non-disease causing CFTR 
mutation. The present study investigated eccrine sweat duct CFTR and ENaC expression, 
and electrolyte composition of control subjects with ‘average’ sweat [NaCl] compared to 
healthy ‘salty sweaters’ and to CF patients with phenotypically high sweat [NaCl] during 
exercise-induced sweating in a hot environment. We hypothesized an inverse association 
between ductal CFTR and/or ENaC expression and sweat [NaCl]; consequently, salty 
sweaters (including CF and healthy subjects) would exhibit decreased CFTR and/or 
ENaC expression at the ductal luminal membrane as compared to individuals with 
average sweat [NaCl]. Since a genetic link to CF has been theorized for individuals with 
high sweat [NaCl] 67, but never directly investigated, incidence of CF mutations within 
the healthy subjects exhibiting large variability in sweat NaCl loss was also investigated.  
 
2.3. Methods 
2.3.1  Preliminary Screening and Subject Selection 
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Recreationally-active young adults (aged 18-40 yrs) were recruited from the 
campus community and endurance sports teams in the area. Normal, healthy volunteers 
(non-CF subjects) participated in a preliminary sweat collection session (i.e., 30-60 min 
of cycling or running at self-selected pace until ~1.5-2 ml of sweat was obtained). Twelve 
individuals were chosen to participate as subjects based on their measured sweat 
composition: six were ‘salty sweaters’ (SS) with sweat [Na+] > 70 mmol/L (Mean ± SD = 
87.6 ± 18.4 mmol/L, range 70-111 mmol/L),  and six individuals (Control) with sweat 
[Na+] < 60 mmol/L mmol/L (Mean ± SD = 41.2 ± 8.4 mmol/L, range 31-55 mmol/L). 
The cut-point of  > 70 mmol/L was used for selecting SS because it represents ~ two SD 
higher than the mean recently reported for regional sweat [Na+] collected under similar 
conditions using the same measurement site (i.e. upper back region) during exercise in 
the heat 117.  
In addition, six young adults with cystic fibrosis (CF) were recruited through the 
Emory University Cystic Fibrosis Center and the local community to participate as 
volunteers.  All CF subjects had sweat [Cl-] in previous diagnostic pilocarpine testing of 
> 75 mmol/L and had ΔF508 mutations on at least one allele.  One CF subject was 
ΔF508/R1162X, one was ΔF508/1717-1G→A, and the remaining four were homozygous 
for ΔF508 mutations.  All CF subjects were in stable clinical status with an FEV1 > 75% 
of predicted value, performed aerobic exercise for a minimum of four hours per week, 
and were cleared by their physician for participation. Informed written consent was 
obtained from both CF and non-CF subjects as approved by the Institutional Review 
Boards at the Georgia Institute of Technology and Emory University School of Medicine.  
 
2.3.2.  Study Design  
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Sweat duct membrane transport protein expression, genotype, and sweat 
[electrolytes] were compared among Control, SS, and CF using a cross-sectional design. 
Identification of SS subjects was performed first through sweat collections in preliminary 
screening. Subsequent matching of each SS subject with a Control subject was performed 
on the criteria that Control have lower sweat [Na+] by at least ~50% (mean ± SD % 
difference in sweat [Na+]  for Control compared to matched SS = -50.7 ± 10.1%). 
Attempts were also made to match all non-CF pairs based on age, gender, anthropometry, 
and training status.  In order, to control for natural heat acclimation (a well-documented 
modifier of sweat composition) 14-17, paired non-CF subjects were tested in the same 
month and not during summer months of June, July, and August. CF subjects were 
matched to non-CF subjects by gender but not necessarily tested within the same month 
as their non-CF counterparts. However, this was not a major study limitation since CF 
sweat composition does not appear modifiable, even with heat acclimation 118.  
Sweat comparison among subject groups was performed at the same relative level 
of dehydration (from 0.5 to 3% body weight loss) and exercise intensity (50% of aerobic 
capacity) to minimize potential effects of these known modifiers on sweat electrolytes. 
Skin sampling via scapular biopsy for examination of sweat ducts was performed at 
approximately the same time of day (mid morning) to minimize potential differences in 
sweat duct membrane transport proteins under circadian influence 119 120.  In order to 
examine the relationship between ductal membrane protein expression and measured 
sweat electrolytes, all biopsies were performed immediately prior to initiation of the 
prolonged exercise protocol circumventing potential differences in ductal channel 
expression invoked by exercise and sweating responses. To avoid potential influence of 
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estrogen and progesterone on ductal channel expression during the luteal phase 121-123, all 
female subjects were tested in the early follicular phase of the menstrual cycle.  
 
2.3.3.  Initial Testing Session: Aerobic Capacity Assessment and Familiarization  
In the first test session, a graded, incremental cycling test was conducted in the 
heat (32-33°C and 35% relative humidity) to determine maximal oxygen uptake 
(VO2max).  Collection of expired gases to determine oxygen consumption (VO2) and 
respiratory exchange ratio (RER), heart rate (HR) and rating of perceived exertion (RPE) 
124 were recorded each minute during the test. Subjects cycled until volitional exhaustion.  
VO2max was considered achieved at test termination based on attainment of at least two of 
the following criteria: a plateau in VO2 during the last two stages (increase < 2.1 
ml/kg/min), a HR within 10 beats/min of age-predicted HRmax, a respiratory exchange 
ratio (RER) > 1.10, or a minute ventilation > 115 L/min.  
A 30 min familiarization ride in the heat (32-33° C and 35% relative humidity) 
followed the VO2max testing to validate the workloads corresponding to a work rate 
estimated to elicit 50%VO2max for the next test session. Nude dry body weight was 
obtained before and after the 30 min ride to determine individual whole-body sweat rates. 
During the familiarization ride, a regional sweat sample was collected from the right 
scapula in order to confirm group placement.   
During the first test session, body composition was assessed for subject matching 
purposes using dual energy X-ray absorptiometery (DEXA) with a Lunar Prodigy whole 
body scanner (GE Medical Systems, Madison, WI). At the completion of this initial 
testing session, subjects were instructed in use of dietary logs to record ingested food and 
beverages for the three days prior to their second testing session.  
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2.3.4.  Second Testing Session: Biopsy and Sweat Collection   
2.3.4.1.  Pre-testing Controls 
Subjects abstained from caffeine (12 hr minimum) and alcohol (32 hr minimum) 
prior to reporting to the research facility for skin biopsy and subsequent exercise testing. 
Twenty-four hour food logs indicated that subjects complied with instructions to 
consume a standardized breakfast meal consisting of bagel, toast, and/or English muffin 
with cream cheese, butter, and/or peanut butter, and juice (any desired, except tomato 
juice) on the morning of testing. There was no difference (p<0.05) among groups in mean 
macronutrient, sodium, or caloric intake relative to body weight (BW) for the three days 
prior to testing.  There was also no difference among groups in macronutrient, sodium, or 
caloric intake relative to BW for the morning of testing except for CF who consumed 
significantly (p=0.02) more fat (0.61 ± 0.3 g/kg) than both Control (0.27 ± 0.1 g/kg) and 
SS (0.28 ± 0.1 g/kg).  To minimize variation in pre-exercise hydration between subjects, 
a euhydration protocol was piloted and instituted. Subjects were given instructions to 
ingest a volume of water equivalent to 12 ml per kg of BW the evening before and 
morning of testing. Furthermore, subjects did not perform physical exercise for 24 hours 
prior to testing. Euhydration was confirmed prior to biopsy and again prior to beginning 
the exercise protocol with measurement of urine specific gravity (USG) < 1.021 125, and 
with subsequent measurement of serum osmolality <290 mOsm 4.  
 
2.3.4.2.  Skin Biopsies  
At the start of the second testing session, skin biopsies were removed from the 
right scapular region, identical to the site of sweat collection in the initial testing session, 
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and contralateral to the collection site of the subsequent prolonged exercise protocol. 
Two full-thickness 4 mm diameter punch biopsies were performed by a dermatologist 
under local anesthetic 62. Biopsied tissue was immediately rinsed in ice-cold lactate 
Ringers and maintained in a second ice-cold lactate Ringers with glucose for tissue 
transport until placed in OCT embedding medium (Miles Inc., Elkhart,, IN) and frozen in 
isopentane cooled in liquid nitrogen.  Frozen biopsies were stored at -80°C until 
sectioned for immunohistochemisty experiments.  
 
2.3.4.3.  Sweat Collection During Prolonged Exercise in the Heat 
Sweat was collected following the skin biopsy during a prolonged exercise 
protocol in an environmental chamber (32-33° C and 35% relative humidity). Intermittent 
cycling was performed at the workload determined previously to correspond to an 
exercise intensity of 50% of VO2max, in 20 minute bouts, separated by five min rest 
periods. No fluids were ingested by subjects during exercise. To estimate whole body 
fluid loss, nude dry body weight was obtained pre-exercise, and during the break periods 
between 20 min cycling bouts, until 3% body weight loss was achieved. Subjects 
undressed and towel dried in a screened area within the heat chamber prior to each 
weighing.  
Sweat was collected with the modified Brisson method 20 using a collection pouch 
constructed with impermeable Parafilm (7 cm x 8 cm) (American Can Co., Greenwich, 
CT) and Opsite wound dressing (10 cm x 14 cm) (Smith & Nephew Inc., Largo, FL). The 
sweat collection site used for all sweat sampling was the scapular region, an accessible 
area that correlates well to whole-body sweat constituent concentrations for [Na+] and 
[Cl-] 18. The skin of the scapula was cleaned with alcohol, deionized water, and sterile 
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gauze, and air dried before application of the collection pouch. Sweat was aspirated from 
the collection pouch every 20 min during cycling. Sweat [Na+], [Cl-], and [K+] were 
measured in triplicate using a chemistry analyzer (Nova 5, Nova Biomedical, Waltham, 
MA).  Frequent removal of accumulated sweat in this protocol likely minimized 
electrolyte leaching from the epidermal layer into the sweat sample. Stable sweat [K+] 
values throughout the collection time points provided evidence that this potential source 
of error was minimal 126. 
 
2.3.5.  Cryosectioning and Immunostaining  
Skin biopsy sections at a thickness of 6 μM were cut using a cryostat (Leica 
CM3050-S, Bannockburn, IL) at a chamber temperature of -20°C, beginning at the 
epidermis and advancing into the dermis. To confirm that sections for immunostaining 
contained ductal portions of the gland, initial sections at each cut depth were treated with 
the nuclear stain hematoxlin and examined under light microscopy for ductal 
characteristics.  Sweat ducts were distinguished from the secretory coil portion of the 
sweat gland by their two cell thickness and well-defined lumen (Fig 1). This was an 
important distinction because it has been known for some time that sweat entering the 
duct after exiting the secretory portion of the gland, ‘primary sweat’, is isotonic to 
extracellular fluid and any decrease in [electrolyte] in the final sweat compared to the 
extracellular fluid reflects the absorptive properties of the sweat duct 98.  In order to 
obtain representation from as much of the entire length of the sweat duct as possible for 
immunofluorescence assay, sections were inspected for presence of ducts at cut depths 
spaced every 90 to 150 μM.  Sections cut in immediate succession from those found to 
contain adequate ducts were picked up onto silane-coated slides (Histobond, Marienfeld, 
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Lauda-Königshofen), air dried, and fixed in a -20°C solution of acetone-methanol (50:50) 
for 10 min.  Following rinsing with phosphate-buffered saline (PBS), plated sections 
were permeabilized in 0.25% Triton in PBS for 10 min. After blocking in 1% bovine 
serum albumin (BSA) in PBS, sections were incubated with primary antibodies overnight 
at 4°C. M3A7 (sc-58615, Santa Cruz Biotechnology, CA), a mouse monoclonal Ab 
raised against recombinant CFTR NBF 2 domain (human origin), was used to detect 
CFTR at a dilution of 1:10. Of the eight main CFTR antibodies established in the 
literature, M3A7 has been used to distinguish healthy and ΔF508 sweat ducts by CFTR 
immunostaining 60 127 128, and has an epitope outside of the ΔF508 deletion. ENaC was 
detected using at a dilution of 1:200 the rabbit polyclonal Ab H-95 (sc-21012, Santa Cruz 
Biotechnology, CA), which targets amino acids 131-225 near the N-terminus of human 
α-ENaC. After thorough washes to remove excess primary antibody, sections were 
incubated for 60 min at room temperature with anti-mouse AlexaFluor488 and anti-rabbit 
AlexaFluor 594 secondary antibodies at a 1:500 dilution (Invitrogen, Life Technologies, 
Carlsburg,CA).  To confirm lack of nonspecific binding by secondary antibodies, 
omission of primary antibodies was performed on some sections from each subject. After 
thorough washes, the sections were stained with 4',6-diamidino-2-phenylindole (DAPI) to 
demonstrate sweat gland morphology, and fixed with a mounting solution. Localization 
of CFTR and ENaC were examined using a Zeiss Axiovision microscope and 
photographed using Zeiss Axiocam-HR (Zeiss, Oberkochen, Germany). Captured images 
were analyzed by a blinded investigator using ImageJ analysis software (National 
Institutes of Health, Bethesda, MD) for quantification of ENaC and CFTR staining (mean 
pixel intensity per area) at ductal lumen. Background fluorescence was subtracted from 
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staining intensity. To assess reproducibility, cryosectioning, immunostaining and image 
analysis was performed on the biopsies of six subjects (3 non-CF pairs) a second time. 
 
2.3.6.  Statistical Analysis  
Results are presented as means ± SE. For each subject, an overall mean pixel 
intensity per area for CFTR, and for ENaC, was computed as an average of all imaged 
ducts’ mean pixel intensity per area values. This consolidated value was used to 
determine between group differences in CFTR and ENaC expression. To minimize the 
effect of batch-to-batch variability in this cross-sectional analysis, staining intensity, 
cryosectioning and immunostaining procedures were always performed in the same run 
for matched subjects. Differences in subject characteristics, sweat electrolytes, and 
expression of membrane channels CFTR and ENaC among subject groups Control, SS, 
and CF were determined using a one way Analysis of Variance (ANOVA). Post-hoc 
testing (Tukey) was performed to determine between-group differences. For the six 
paired non-CF subjects for whom repeated immunostaining was performed, coefficient of 
variation for relative expression, calculated as mean pixel intensity per area divided by 
the total mean pixel intensity per area of both subjects within a matched pair, was 
determined with Pearson-Product-Moment Correlation. The relationship between sweat 
electrolytes and mean pixel intensity per area of CFTR staining, and ENaC staining, was 
analyzed using Pearson-Product Moment Correlation. All statistical testing was 
performed using SPSS (version 17.0, SPSS, Inc., Chicago, IL).  An α level of 0.05 was 
used to indicate statistical significance. 
 
2.3.7.  Genetic Testing 
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A venous sample collected from non-CF subjects at the start of their second 
testing session was used for genetic testing. Genomic DNA (gDNA) was isolated from 
whole blood and tested by an outside laboratory (Emory Genetics) using an allele-
specific primer extension assay (Tag-It Cystic Fibrosis Kit, Luminex, Toronto). This 
assay tested for 39 of the most common CF mutations in the US, including the 
recommended ACMG panel 129 of 23 common mutations. Mutations tested in this panel 
were: ΔF508, R334W, S549N, 3659delC, ΔI507, I347P, A559T, S1255X, 1898+1G>A, 
R347H, N1303K, 1898+5G>T, 3876delA, A455E, 394delTT, 2183GG>A, 3905insT, 
3120+1G>A, V520F, 2184delA, G85E, Y1092X, 711+1G>T, 2307insA, Y122X, S549R, 
M1101K, 1078delT, 2789+5G>A, G551D, G542X, 621+1G>T, R560T, W1282X, 1717-
1 g>a, 3849 + 10KbC>T, R553X, R117H, and R1162X.  
 
2.4.  Results 
 
2.4.1.  Subjects 
 Mean (± SE) physical characteristics are presented in Table 2.1. The two groups 
of non-CF subjects (those with high and low sweat [Na+]) were similar in their physical 
characteristics and exercise training volume. As expected given the nature of the disease, 
CF subjects were younger, and had lower aerobic capacity and weekly training volume 
compared to non-CF subjects. 
 
2.4.2.  Sweat Electrolytes and Sweat Rate 
Mean (±SE) sweat electrolytes presented in Table 2.2 are calculated for each 
subject as their average across all collections (from 0.5 to 3% dehydration).  As expected 
given the procedure for the subject selection, sweat [Na+] and [Cl-] were higher for SS  
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and CF compared to Control (p<0.001). Sweat [Na+] and [Cl-] values for CF were also 
higher than SS (p<0.001). Consistent with reports in the literature for CF sweat 
electrolyte composition 2 64, CF sweat [K+] tended to be higher than non-CF groups (p= 




Table 2.1: Mean (±SE) physical characteristics, exercise training volume, and aerobic 
fitness (VO2max) of Control, non-CF salty sweaters (SS), and cystic fibrosis (CF) subjects 
(n=18). * Significantly < Control, # CF significantly < SS (p<0.05). 
 
Physical Characteristics Control SS CF 
Gender 4 m, 2 f 4 m, 2 f 4 m, 2 f 
Age (yrs) 31.2 ± 2.0 31.2 ± 3.0    22.2 ± 1.0 *# 
Weight (kg) 68.4 ± 5.7 73.2 ± 6.4 64.0 ± 5.7 
Body Fat (%) 15.0 ± 3.3 18.0 ± 3.5 15.3 ± 2.3 
Training Volume (hrs/wk) 12.2 ± 2.0 11.8 ± 1.8       5.1 ± 0.7 *# 







Table 2.2: Mean (±SE) sweat electrolytes concentration (indicated by brackets), and 
sweat rate (SR) relative to body weight (BW), of Control, non-CF salty sweaters (SS), 
and cystic fibrosis (CF) subjects (n=18). * Significantly > Control (p<0.005), # CF 
significantly > SS (p<0.05).  
 
Sweat Characteristics Control SS CF 
Sweat [Na+] (mmol/L)   46.2 ± 4.2    94.9 ± 6.2 *     132.6 ± 2.6 *# 
Sweat [Cl-] (mmol/L)   47.8 ± 3.6    87.1 ± 7.1 *     127.0 ± 4.9 *# 
Sweat [K+] (mmol/L)     4.9 ± 0.2   4.3 ± 0.1         7.4 ± 0.6 # 






 [Na+] and [Cl-] increased with progressive dehydration in all three groups. 
Interestingly, there was a greater relative increase in sweat [Na+] (p<0.05) with 
dehydration in Control (mean % change of 17.7 ± 3.2%) compared to CF (4.2 ± 2.1%), 
and tended to be greater (p=0.15) in Control compared to SS (8.7 ± 4.2%).  There was 
also a trend (p=0.10) for greater relative increase in sweat [Cl-] with dehydration in 
Control (16.5 ± 3.9%) compared to CF (6.2 ± 1.9%). 
As designed, Control, SS, and CF achieved similar percent body weight loss (% 
dehydration) at the termination of exercise (3.0 ± 0.06% for Control, 2.9 ± 0.07% for SS, 
and 2.9 ± 0.07% for CF). There was also no difference among groups in sweat rate (SR) 
expressed relative to BW (Table 2.2).  
 
2.4.3.  CFTR and ENaC Expression at Ductal Lumen 
Sections from the ductal portion of the sweat gland were distinguished 
morphologically from sections of the secretory coil portion of the gland by nuclear 
staining. The ductal segment (coiled and straight portion) has a two cell layered wall, as 
indicated by two layers of nuclei surrounding a clearly defined lumen (examples shown 
with arrow, Fig 2.1a and Fig 2.1b). In contrast, the secretory coil segment is only one cell 
wall thick, has a more poorly defined lumen, and is usually larger in diameter with larger 
nuclei (examples labeled with ‘S’, Fig 2.1a and Fig 2.1b). This distinction is important 
because CFTR and ENaC staining was quantified only in the lumen (example is circled in 
Fig 2.1b) of images identified clearly as ductal segments. Representative epifluorescence 
images of immunostaining for Control (row 1), SS (row 2), and CF (row 3) are presented  
in Fig 2.2.  As expected, CFTR (stained green) was localized primarily to the ductal 










Fig. 2.1: Eccrine sweat gland tubules in biopsied human skin. To demonstrate 
morphology of secretory coil (S) and reabsorptive duct (arrows), 6 µm cryosections were 
stained with (a and b) hematoxylin (brightfield image original magnifications 20X) and 
(c) 4',6-diamidino-2-phenylindole (DAPI, epifluorescence image original magnification 
40X). An example of a ductal lumen (outlined) is shown in part (c). 
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distributed thoughout the cytoplasm.  Immunofluorescent staining for CFTR and ENaC 
was absent on negative control sections not incubated with primary antibodies (Fig 2.2, 
4th column). In the three subject pairs for which repeat sectioning and immunostaining 
was performed, the coefficients of variation (CV) between initial and repeat relative 
expression of CFTR were 7.2%, 4.0%, and 4.3% (mean 5.5 ± 1.8%). The relative 
expression of ENaC in these repeated pairs had CVs of 1.7%, 19.1%, and 0.4% (mean 7.1 
± 10.4%).  
CFTR expression was lower (p< 0.05) in SS than Control (Figs 2.2 and 2.3).  
CFTR expression in CF was lower than Control (p<0.005), but not SS (p=0.241) (Fig 2.2 
and 2.3).  ENaC expression was not different (p=0.957) among groups (Fig 2.2 and 2.3).  
 
2.4.4.  Relationship between Channel Expression and Sweat Electrolytes 
 
Significant inverse relationships were observed between CFTR expression and 
sweat [Na+] (r = -0.639, p<0.005) (Fig 2.4), and for CFTR and sweat [Cl-] (r = -0.594, 
p<0.010); namely, greater sweat Na+ and Cl- was associated with lower sweat duct 
CFTR. When only non-CF subjects (n=16) were examined, the same relationship with 
CFTR expression persisted but did not reach significance for sweat [Na+] (r = -0.461, 
p=0.132), or for sweat [Cl-] (r = -0.402, p=0.195).  There was also no significant 
relationship between CFTR and sweat electrolytes in the six CF subjects (r = 0.143, 
p=0.788 for Na+; and r = 0.304, p=0.558 for Cl-).  
Consistent with the finding of similar ENaC expression among groups, there was 
no significant relationship between ENaC expression and sweat [Na+] (r = 0.211, 







Fig. 2.2: Immunofluorescence staining of the eccrine sweat gland reabsorptive duct in 6 
µm cryosections of biopsied human skin. Anti-CFTR labeling with M3A7 (column 1, 
green), and anti-αENaC labeling with H-95 (column 2, red) revealed immunoreactivity 
particularly corresponding to the luminal plasma membranes. Overlay of images from 
column 1 and 2 demonstrates where immunoreactivity to CFTR and ENaC occurred at 
the same location (column 3, yellow). Sections without primary antibodies did not show 
immunoreactivity (column 4). CFTR staining was significantly more pronounced in 
Control subject with mean sweat [Na+] of 45 mmol/L and [Cl-] of 44 mmol/L (row 1) 
compared to paired non-CF salty sweater subject (SS) with sweat [Na+] of 88 mmol/L 
and [Cl-] of 85 mmol/L (row 2), and compared to paired cystic fibrosis (CF) subject 
(ΔF508/1717-1G→A) with sweat [Na+] of 136 mmol/L and [Cl-] of 130 mmol/L (row 3). 
Original magnification 40x. 
 
 
relationship when analyzed for only non-CF subjects (r = 0.285, p=0.369 for Na+; and r = 
0.398, p=0.200 for Cl-). However, unlike in non-CF subjects, there was a significant 
positive relationship in CF for ENaC and sweat [Cl-] (r = 0.846, p = 0.034), with a 
tendency for sweat [Na+] in CF subjects to be positively correlated with ENaC as well (r 
= 0.741, p = 0.092).   
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Fig. 2.3: Mean (±SE) sweat duct luminal membrane channel expression (mean pixel 
intensity per area) for cystic fibrosis transmembrane conductance regulator (CFTR, 
green), and epithelial sodium channel (ENaC, red) of Control subjects with mean±SE 
sweat [Na+] of 46.2 ±4.2 and [Cl-] of 47.8 ±3.6 mmol/L (solid bars), non-CF salty 
sweaters (SS) with mean±SE sweat [Na+] of 94.9 ±6.2 and [Cl-] of 87.1 ±7.1 mmol/L 
(striped bars), and cystic fibrosis (CF) subjects with mean±SE sweat [Na+] of 132.6 ±2.6 
and [Cl-] of 127.0 ±4.9 mmol/L (checkered bars). * Significantly < Control (p<0.05). 
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Fig. 2.4: Relationship between sweat duct luminal membrane channel expression and 
[Na+] of thermally-induced sweat of CF (circles), non-CF salty sweaters (SS, diamonds), 
and Control (triangles) subjects. A significant inverse relationship (green line, r=-0.639, 
p<0.005) was demonstrated for mean pixel intensity per area of ductal luminal membrane 
CFTR (green symbols) and [Na+] of sweat collected during exercise in the heat to 3% 
dehydration. No relationship (p=0.401) was observed for mean pixel intensity per area of 






2.4.5.  Genetic Testing 
 
Genetic testing determined that none of the healthy subjects were heterozygous 
for any of the 39 most common disease-causing CFTR mutations in the US. While the 
testing panel used in this study is considered to accurately predict 99% of all non-
Hispanic Caucasian carriers of a disease-causing CFTR mutation in the US 129, it does not 
detect CFTR mutations with milder or unknown phenotypes.  
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2.5.  Discussion 
 
This study investigated a potential mechanism that might account for the known 
inter-individual variability of NaCl loss in humans during thermoregulatory sweating. 
Given that primary sweat produced by the secretory coil of the sweat gland is isotonic to 
extracellular fluid 38 97, and that extracellular [NaCl] is maintained in a tight physiological 
range across humans, we examined the reabsorptive duct of the sweat gland for 
differences in the abundance of membrane transport machinery that might explain 
variable electrolyte reabsorption. To accomplish this, measurement of sweat electrolytes 
(during exercise in the heat eliciting moderate dehydration) and luminal membrane CFTR 
and ENaC expression was performed in healthy subjects with salty sweat compared to 
those with ‘typical’ sweat [NaCl], and compared to subjects with CF. Immunoreactivity 
to anti-CFTR was localized primarily to the apical membrane of the inner luminal ductal 
cells, the principal site of NaCl reabsorption 38. Immunoreactivity to anti-αENaC was 
greatest at the apical membrane of the inner luminal ductal cells, but was also observed 
between the inner and outer luminal ductal cells, and generally distributed more diffusely 
throughout the cell than CFTR. Intriguingly, a significant association was demonstrated 
for ductal luminal membrane CFTR expression and thermoregulatory sweat [NaCl]. 
Further, CFTR expression in sweat ducts of healthy salty sweaters was found to be less 
than in Control and not significantly different than in CF subjects.  
In light of this finding of altered CFTR expression in SS, it is somewhat 
surprising then that none of these subjects were identified as heterozygotes for CF. This 
suggests that: 1) either the lower CFTR expression in the SS group was not related to CF 
carrier status, or, 2) the testing panel utilized was not complete and thus failed to detect 
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all other potential CFTR gene mutations. The test panel utilized in this study is the most 
commonly used for CF genetic testing to detect the most frequently occurring mutations 
of the CFTR gene that are associated with development of the classical form of the 
disease. Approximately 4% of individuals of European Caucasian descent are carriers of 
one of these CFTR mutations 105 106. Over 1600 mutations and over 300 polymorphisms 
of the CFTR gene have been identified 130, however, with no known clinical 
abnormalities associated with most 70. The prevalence of carriers in the population for 
one of the many other CFTR variants is not known.  Thus, it is still possible that a less 
common CFTR gene mutation associated with a non-disease causing phenotype, perhaps 
only manifesting in the sweat gland, was responsible for the lower CFTR expression and 
the higher sweat [NaCl] in SS. Given that SS were all well-trained endurance athletes 
who reported no chronic CF-like conditions (e.g. pancreatitis, recurrent sinus infections), 
this is more likely.  Gene sequencing of non-CF subjects would be required to determine 
if such a discreet CF gene polymorphism is present with greater frequency in SS. Thus, 
we cannot yet exclude the possibility that a relationship exists between excess NaCl loss 
in sweat and CF carrier status.  
While CFTR expression was reduced in SS and CF, ENaC expression was 
remarkably similar among groups. In addition to serving as a cAMP-activated Cl- 
channel, CFTR plays a critical role in transepithelial absorption through its influence on 
other ion transport proteins, including ENaC 131-133. Functionally dependent on CFTR in 
several absorbing tissues including those of the sweat gland 100 134, ENaC conductance for 
Na+ reabsorption should not be assumed intact when ENaC expression is normal. 
Therefore, it is reasonable that [Na+] in sweat was markedly higher in SS despite no 
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difference in ENaC expression, and that no association was determined between sweat 
[Na+] and luminal expression of ENaC.  
While our findings indicate that reduced CFTR expression at the luminal 
membrane of the sweat duct is related to the high sweat [NaCl] found in some 
apparently-healthy individuals, reduced CFTR expression accounts for only 21% of the 
variance in sweat [Na+] within non-CF subjects which suggests that other factors may 
also play a mechanistic role.  The possibility of other contributing factors is also 
suggested by the observation that sweat [NaCl] in SS was approximately twice that of 
Control while CFTR expression in SS compared to Control was only 25% less. Further, 
CF sweat [NaCl] was almost three times higher than Control yet mean CFTR expression 
in CF compared to Control was only approximately 50% less. It is not possible with these 
data to assess how differences in overall channel function for SS and CF compared to 
Control contributed to differences in their sweat [NaCl]. However, functional impairment 
of transepithelial transport channels may explain how sweat [NaCl] was almost twice that 
of matched Control despite CFTR expression that was similar for one of the six SS 
subjects, and unexpectedly greater for another of the six SS subjects, compared to 
Control counterparts.   
Functional impairment of CFTR was almost certainly an additional factor in the 
high sweat [NaCl] for CF subjects, all of whom had ΔF508 mutations on at least one 
allele, and four of whom were homozygous for ΔF508.  ΔF508 CFTR is translated, but 
misprocessing within the endoplasmic reticulum results in most of the protein being 
directed toward degradation instead of insertion into the plasma membrane 135 136. 
Therefore, it was expected that luminal CFTR immunostaining would be largely absent in 
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CF as other investigators have demonstrated for ΔF508 sweat ducts 60 128. Interestingly, 
there was not a complete absence of luminal CFTR staining in CF tissue.  While many 
ductal sections showed scarce immunoreactivity to M3A7, some CF ducts were found to 
stain for CFTR similar to that in non-CF SS tissue, and overall mean CFTR expression in 
CF was still approximately half that of Control. This is unexpected as immunostaining 
with M3A7 at similar dilutions has previously been characterized by other investigators 
127 128. One possible explanation for the slightly greater CFTR expression in these 
subjects compared to ΔF508 CF in previous studies is an increase secondary to patient 
medications. Aminoglycosides, especially tobramycin, are frequently prescribed for CF 
patients to combat respiratory infections from the opportunistic bacterial pathogen 
Pseudomonas aeruginosa 137.  It is not known if aminoglycoside therapy results in 
pharmacologic effects that extend beyond control of infections. Four out of six CF 
subjects in this study were on tobramycin or other aminoglycosides at the time of 
participation. An important difference observed for CF compared to non-CF was the lack 
of association between sweat duct CFTR expression and sweat [Na+] or [Cl-].  Despite 
apparent presence of CFTR (albeit reduced) at the CF ductal lumen, NaCl sweat loss was 
still almost three fold higher for CF than Control. This is consistent with the belief that 
for the few ΔF508 CFTR channels that are somehow trafficked to the luminal membrane, 
channel function is compromised, possibly due to reduced channel activity 138 and/or 
stability 139. The unexpected positive relationship between ENaC and sweat [Na+] and 
[Cl-] in CF subjects is congruent with the observed upregulation of ENaC expression in 
CF nasal epithelium 140.   
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 It is also possible that expression or function of ductal membrane transport 
proteins other than CFTR and ENaC is additionally reduced in SS or CF. One possibility 
is a Na+/H+ exchanger (NHE1), thought to be responsible for intracellular pH regulation 
in ductal epithelium in concert with an apical concanamycin A-sensitive proton pump 50 
51. NHE1 is present at the basolateral and lateral membranes of human eccrine sweat duct 
cells 51 52 and control of ductal intracellular pH may be mechanistically linked to luminal 
Na+ removal 51. A deficiency in NHE1 expression or function would lead to a rise in 
intracellular Na+, thereby reducing the gradient for luminal Na+ entry through ENaC. 
This would decrease luminal Na+ reabsorption and acidification of sweat. While not 
examined in this study, it would be interesting to determine if sweat pH is elevated along 
with [NaCl] in apparently-healthy salty sweaters.   
Looking for other potential mechanisms that can explain the remaining 
variability, it has been suggested that aquaporins might play a role in the saltiness of 
sweat particularly as a possible point of control for acute regulation of the sweat gland by 
vasopressin 6 141. However, while secretory coil cells of mice and rat paw sweat glands 
appear to specifically express AQP5 142, there is not good evidence supporting its 
presence in the cells of the human sweat duct.  AQP5 is more likely to be found in the 
secretory not ductal portion of the human sweat gland, as has been shown to be the case 
in other glandular epithelium 143-145. If AQP5 or other aquaporins are indeed localized to 
the secretory coil of the human sweat gland, they would not participate in the ductal 
modification of primary sweat prior to final sweat excretion. However, it is conceivable 
that decreased aquaporin expression or function in the coil could ultimately contribute to 
a more concentrated final sweat if transcellular water transport (into the lumen) during 
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the formation of primary secreted sweat is decreased. Volume of sweat produced would 
also be compromised, though, and salty sweat is not associated with a lower rate of 
sweating as observed in both CF and SS in this study. Nonetheless, further investigation 
is needed to clarify the role that aquaporins may play in the human sweat gland and if 
variable expression or function is a contributing factor to the excretion of saltier sweat in 
some individuals.  
 
2.6.  Conclusion 
 In the present study, we have demonstrated that reduced expression of the Cl- 
channel CFTR at the apical membrane of the sweat gland’s reabsorptive duct may 
contribute to greater loss of NaCl in some apparently healthy individuals during 
thermoregulatory sweating. CF subjects had significantly lower ductal CFTR expression 
compared to healthy salty sweaters; moreover, these healthy salty sweaters had lower 
CFTR expression than their control counterparts.  Differences in CFTR-mediated Cl- and 
Na+ transport in ductal NaCl reabsorption could be a potential mechanism underlying 
variability in human sweat Na (.i.e. promoting a CF-like phenotype). However, genetic 
testing failed to establish a link between healthy salty sweaters and one of the 39 most 
common disease-causing CFTR mutations; but, a relationship to other untested CFTR 
variants cannot be entirely ruled out. Further research is needed to investigate whether 
other epithelial transport proteins contribute to the variability in human eccrine sweat 
sodium chloride composition.  
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CHAPTER 3   
 
 
HIGH SWEAT SODIUM LOSSES DO NOT DIFFERENTIALLY 
ALTER PERCEIVED THIRST DURING EXERCISE IN THE HEAT 
  
3.1.  Abstract 
 Purpose:  Eccrine sweat sodium concentration ([Na+]) varies greatly among 
individuals; but, whether this differentially affects physiological responses that dictate 
thirst during prolonged exercise in the heat has not been investigated.  Methods:  A total 
of twenty-one physically-active young adults performed cycling in the heat (32-33°C, 
35% RH) at 50% of VO2max until 3% body weight loss. Seven healthy subjects with high 
sweat [Na+] (SS) were matched by physical characteristics, training, and acclimation 
status to healthy subjects with average sweat [Na+] (Control).  Six physically-active 
cystic fibrosis patients (CF), who phenotypically excrete extremely salty sweat, served as 
a third group. Results: Mean (± SD) regional sweat [Na+] (91.0 ± 17.3) and [Cl-] (84.0 ± 
17.8 mmol/L) for SS were higher (p<0.001) than Control (43.7 ± 9.9, and 41.9 ± 6.9 
mmol/L, respectively). CF sweat [Na+] (132.6 ± 6.4) and [Cl-] (127.0 ± 12.1) were also 
higher compared to Control (p<0.001) and SS (p<0.005).  Whole body sweat rate relative 
to body mass (12.3 ± 2.5 mL/kg/hr) and exercise time required to reach 3% dehydration 
(125.7 ± 22.0 min) did not differ among groups. Rise in serum osmolality with 
dehydration was lower (p<0.05) in CF (6.1 ± 4.3 mOsm/kgH2O), and SS (8.4 ± 3.0 
mOsm/kgH2O) compared to Control (14.8 ± 3.5 mOsm/kgH2O). Relative change in 
plasma volume (%ΔPV) was significantly (p<0.05) greater in CF (-19.3 ± 4.5%), and SS 
 40
(-18.8 ± 3.1%) than Control (-14.3 ± 2.3%). Rating of thirst relative to dehydration and 
change in plasma aldosterone, vasopressin, and angiotensin II was not different among 
groups. During recovery, serum [Na+] (by 2.8 ± 2.1 mmol/L) and [Cl-] (by 4.8 ± 1.3 
mmol/L) decreased below resting values in CF with ingestion of a sports beverage 
despite 30% lower (p<0.05) volume ingested ad libitum compared to SS and Control. 
Conclusion:  Individuals with CF and healthy individuals with high sweat [Na+] exhibit 
attenuated blood osmolality but greater relative plasma fluid loss at moderate levels of 
dehydration, resulting in similar ratings for thirst as Controls during exercise in the heat.  
However, drinking behavior in CF, unlike SS, was altered when presented with hypotonic 
fluids in recovery, presumably in response to the reduction in blood [NaCl].   
 
3.2.  Background 
3.2.1.  Variability in Human Eccrine Sweat Electrolytes 
There is tremendous inter-individual variability in eccrine sweat sodium 
concentration ([Na+]) in healthy subjects tested under similar conditions that control  
methodological factors related to sweat collection and analysis 2-4 146 147. Representing the 
most extreme physiological example of extra salty sweat, [Na+] of sweat from individuals 
with the lethal autosomal recessive disease cystic fibrosis (CF) is typically three to five 
times higher than average due to defective chloride (Cl-) and sodium (Na+) channel 
transport in the CF sweat duct 53 54. ΔF508 is the most frequent mutation causing CF in 
the US, with more than 90% of all CF patients carrying at least one allele 148.  As a result 
of the misprocessing and protein degradation associated with this mutation, CFTR fails to 
localize correctly at the sweat duct membrane 148 149 and results in sweat that is nearly 
isotonic to plasma.  Regardless of acclimation status (which is known to modulate sweat 
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electrolytes even within an individual 14-17 33), some apparently healthy (non-CF) 
individuals also excrete sweat containing high [Na+], with values approaching that of CF 
64. The implications of excess sweat sodium losses on physiological functions (e.g., 
thermoregulation, fluid balance, cardiovascular regulation) are not fully understood, 
especially for humans engaging in exercise where dehydration may occur. 
 
3.2.2.  Physiology of Thirst 
 Thermoregulatory sweating during exercise typically results in increased blood 
osmolality due to the relatively greater loss of water compared to electrolytes. There is a 
strong relationship between the sensation of thirst and blood osmolality 71-73. As 
osmolality increases, arginine vasopressin (AVP) release increases, mediated by 
signaling from osmoreceptors of the preoptic anterior hypothalamus 77. As little as a 1 or 
2% rise in osmolality induces release of this dipsogenic hormone 73-77, AVP, which 
results in insertion of aquaporin-2 channels into the apical membrane of the collecting 
duct and subsequently increases renal fluid retention 77. Vasopressin also stimulates a 
behavioral mechanism (drinking) for the correction of hyperosmolality by its influence 
on thirst drive 73-76. Individuals with high sweat [Na+] have proportionately less free 
water (FW) loss during sweat-induced dehydration 79; however, the impact of lower FW 
loss on their hyperosmolality-dependent sensitivity of thirst relative to hydration deficit is 
not well known. This has important implications during exercise in the heat, because 
attenuated thirst and diminished drinking may promote a state of involuntary dehydration 
71, with subsequent challenges for cardiovascular responses and thermoregulation.  
 
3.2.3.  Adequacy of Thirst Mechanism during Prolonged Exercise in the Heat 
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 There is debate among exercise physiologists whether reliance on thirst is 
recommended during exercise in the heat.  It has been common practice to recommend 
programmed drinking 84-87 due to a potential lag in the thirst mechanism leading to 
inadequate fluid balance to maintain exercise performance. An alternative view is that 
thirst-guided drinking in humans is sufficient for fluid balance during exercise (as in 
other mammalian species) and that not relying upon the thirst drive could potentially lead 
to excess consumption of fluids and increased risk of hypervolemic hyponatremia 89 90 93 
150.  It is possible that both views are correct, but that the thirst drive is not reliable for all 
individuals.  It has been observed that individuals with CF, who phenotypically exhibit  
elevated sweat [NaCl], may underestimate their fluid needs during exercise in the heat, 
resulting in a state of ‘involuntary dehydration.’ It has been suggested that this may be 
due to an attenuated hyperosmolality trigger for thirst 83 151 152. The impact of variability 
in sweat [Na+] on thirst sensation has not been previously explored. The implications 
could be particularly important for individuals with high sweat [Na+] such that, if thirst 
does not match actual fluid needs due to sweating, they may be at greater risk for 
dehydration if dependent upon thirst-guided drinking during prolonged activity in the 
heat. However, to recommend regimented drinking for these individuals is also possibly 
deleterious because the combination of excess sweat [Na+] loss coupled with excessive 
water intake could result in lower serum sodium and risk for hyponatremia during 
prolonged activity in the heat 26 70 95 96.   
 For individuals with CF who excrete extremely salty sweat, the impact of a 
potentially greater cumulative sweat NaCl loss on blood electrolytes and thirst sensitivity 
has not been investigated systematically. With improved management of respiratory and 
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digestive sequelae, participation in recreational and competitive sports is increasing for 
patients with CF. Exercise is encouraged, as higher levels of aerobic fitness in CF 
patients have been shown to be associated with an increased life expectancy 153 154. 
However, with electrolyte and fluid losses during prolonged exercise not clearly defined 
for CF, fluid replacement guidelines have yet to be established for this population to 
maximize safety and performance during exercise in the heat. To our knowledge, CF 
responses to thermally-induced sweating during exercise have been investigated in only 
four studies to date in the literature 83 118 151 155. However, there are methodological 
limitations in some aspects of these studies, such as uncontrolled volume of fluid 
ingestion during exercise between groups 83 118 155, inadequate yield in blood sampling 151, 
use of CF subjects with low fitness 83 or unequal fitness levels between CF and non-CF 
groups 118.  In the present study, exercise-trained CF patients were compared to healthy 
exercise-trained individuals with high and “normal” sweat NaCl loss to determine the 
effect of dehydration on physiological responses and fluid/electrolyte balance during 
exercise.  It was hypothesized that individuals with high sweat [NaCl] (e.g. both healthy 
and CF) would have attenuated increases in blood osmolality and thus decreased osmotic 
stimulation of thirst relative to change in hydration status compared to individuals with 
normal sweat [NaCl].  
 
3.3.  Methods 
3.3.1.  Subjects 
3.3.1.1.  Preliminary Screening and Subject Selection 
Recreationally-active young adults (aged 18-40 yrs) were recruited from the 
campus community and endurance sports teams in the area. Normal, healthy volunteers 
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(non-CF subjects) participated in a preliminary sweat collection session (i.e., 30-60 min 
of cycling or running at self-selected pace until 1.5-2 ml of sweat was obtained). Sixteen 
individuals were chosen to participate as subjects based on their measured sweat 
composition: eight were ‘salty sweaters’ (SS) with sweat [Na+] > 70 mmol/L (Mean ± SD 
= 87.6 ± 18.4 mmol/L, range 70-111 mmol/L),  and eight were normal (Control) with 
sweat [Na+] < 60 mmol/L mmol/L (Mean ± SD = 41.2 ± 8.4 mmol/L, range 31-55 
mmol/L). The cut-point of  > 70 mmol/L was used for selecting SS because it represents 
~ 2 SD higher than the mean recently reported for regional sweat [Na+] collected under 
similar conditions and with a similar technique from the upper back region during 
exercise in the heat 117.  
In addition, six young adults with cystic fibrosis (CF) were recruited through the 
Emory University Cystic Fibrosis Center and the local community to participate as 
volunteers.  All CF had sweat [Cl-] in previous diagnostic pilocarpine testing of > 75 
mmol/L.  One CF subject was ΔF508/R1162X, one was ΔF508/1717-1G→A, and the 
remaining four were homozygous for ΔF508 mutations.  All CF were in stable clinical 
status with an FEV1 > 75% of predicted value, performed aerobic exercise for a minimum 
of four hours per week, and were cleared by their physician for participation. Informed 
written consent was obtained from both CF and non-CF as approved by the Institutional 
Review Boards at the Georgia Institute of Technology and Emory University.  
 
3.3.1.2.  Study Design and Subject Characteristics 
 Responses to progressive dehydration induced by prolonged exercise in the heat 
in Control, SS, and CF were compared using a cross-sectional design. Identification of SS 
subjects was performed first through sweat collections in preliminary screening. 
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Subsequent matching of each SS subject with a Control subject was performed on the 
criteria that Control have lower sweat [Na+] by at least ~50% (mean ± SD % difference in 
sweat [Na+]  for Control compared to matched SS = -53.2 ± 11.6%). Non-CF pairs were 
also matched by age, gender, anthropometry, training history, and aerobic capacity. 
Subject characteristics are presented in Table 3.1. Sample size among the groups was not 
equally balanced due to difficulty in recruiting CF subjects and a subject drop-out in SS. 
Compared to non-CF groups, CF were younger, had lower aerobic capacity, and lower  
 
 
Table 3.1: Mean (±SD) physical characteristics, exercise training volume, and aerobic 
fitness (VO2max) of Control, non-CF salty sweaters (SS), and cystic fibrosis (CF) subjects 
(n=21). * Significantly < Control and SS (p<0.05). 
 
 
 Control SS CF 
Gender 8 m, 2 f 7 m, 2 f 4 m, 2 f 
Age (yrs) 30.5 ± 5.7 31.6 ± 6.5   22.2 ± 4.5 * 
Weight (kg)   68.8 ± 11.8   74.4 ± 14.7   63.7 ± 13.9 
Body Fat (%) 14.5 ± 6.8 17.3 ± 8.1 15.3 ± 5.6 
Training Volume (hrs/wk) 11.1 ± 4.9 12.0 ± 4.0     5.1 ± 1.6 * 
VO2max (ml/kg/min) 52.8 ± 5.7 50.1 ± 6.5   39.9 ± 4.5 * 





weekly training volume as expected given the nature of the disease. Paired non-CF 
subjects were tested in the same month, and between the months of December through 
May, to control for natural heat acclimation (a well-documented modifier of sweat 
composition) 14-17. CF subjects were matched to non-CF subjects by gender but not 
necessarily tested within the same month as their non-CF counterparts. However, this was 
not a major study limitation since CF sweat composition does not appear to change with 
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heat acclimation 118. All female subjects were tested in the early follicular phase of the 
menstrual cycle to avoid estrogen and progesterone influences on osmotic thirst and AVP 
responses during the luteal phase 123.  Comparison of collected sweat among groups was 
performed at the same relative dehydration and exercise intensity to minimize potential 
effects of these known modifiers on sweat electrolytes.  
 
3.3.2. Initial Testing Session: Aerobic Capacity Assessment and Familiarization  
In the first test session, a graded, incremental cycling test was conducted in the 
heat (32-33°C and 35% relative humidity) to determine maximal oxygen uptake 
(VO2max).  Collection of expired gases to determine oxygen consumption (VO2) and 
respiratory exchange ratio (RER), heart rate (HR) and rating of perceived exertion (RPE) 
124 were recorded during each stage the test. Subjects cycled until volitional exhaustion. 
VO2max was considered achieved at test termination based on attainment of at least two of 
the following criteria: a plateau in VO2 during the last two stages (increase < 2.1 
ml/kg/min), a HR within 10 beats/min of age-predicted HRmax, a respiratory exchange 
ratio (RER) > 1.10, or a minute ventilation > 115 L/min.  
A 30 min familiarization ride in the heat (32-33° C and 35% relative humidity) 
followed the VO2max testing to validate the workloads corresponding to a work rate 
estimated to elicit 50%VO2max for the next test session. Nude dry body weight was 
obtained before and after the 30 min ride to determine individual whole-body sweat rates. 
During the familiarization ride, a regional sweat sample was collected from the right 
scapula in order to confirm group placement.  
Body composition was assessed for subject matching purposes using dual energy 
X-ray absorptiometery (DEXA) with a Lunar Prodigy whole body scanner (GE Medical 
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Systems, Madison, WI). At the completion of their initial testing session, subjects were 
instructed in use of dietary logs to record ingested food and beverages for the three days 
prior to their second testing session.  
 
3.3.3.  Second Testing Session: Dehydration Induced by Prolonged Cycling in Heat 
3.3.3.1.  Pre-testing Controls 
Subjects abstained from caffeine at least 12 hours prior and alcohol at least 32 
hours prior to reporting to the lab for testing. Twenty-four hour food logs indicated that 
subjects complied with instructions to consume a standardized breakfast meal consisting 
of bagel, toast, and/or English muffin with cream cheese, butter, and/or peanut butter, and 
orange juice (if desired) on the morning of testing. There was no difference (p>0.05) 
between SS and Control in macronutrient, sodium, or caloric intake relative to body 
weight (BW) for the morning of testing, and for the average of three days prior to testing. 
CF consumed significantly more (p<0.05) total calories (14.7 ± 7.1 kcals/kg of BW) and 
protein (0.6 ± 0.3 g/kg BW) than SS (6.5 ± 2.7 kcals/kg, 0.3 ± 0.2 g/kg protein), and 
significantly more (p<0.05) fat (0.6 ± 0.3 g/kg) than both Control (0.3 ± 0.1 g/kg) and SS 
(0.2 ± 0.1 g/kg) the morning of testing. However, there was no difference (p>0.05) from 
Control or SS for CF 3 day average macronutrient, sodium, or caloric intake relative to 
BW.  
To minimize variation in pre-exercise hydration between subjects, a euhydration 
protocol was piloted and instituted. Subjects were given instructions to ingest a volume of 
water equivalent to approximately 12 ml of per kg of BW the evening before and 
morning of testing. Furthermore, subjects did not perform physical exercise for 24 hours 
prior to testing. Euhydration was confirmed with measurement of urine specific gravity 
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(USG) < 1.021 125 one hour prior to, and immediately prior to beginning the exercise 
protocol, and with subsequent measurement of serum osmolality < 290 mOsm 4. All 
subjects began the protocol well-hydrated with no difference (p<0.05) among groups in 
initial serum osmolality (Control 279.9 ± 2.8, SS 282.8 ± 2.5, and CF 284.0 ± 3.2 
mOsm), or USG (Control 1.006 ± 0.002, SS 1.006 ± 0.001, and CF 1.009 ± 0.004). 
 
3.3.3.2.  Testing Protocols: Exercise and Recovery 
The experimental test protocol consisted of prolonged cycling exercise in a heated 
environmental chamber (32-33° C and 35% relative humidity). Cycling was performed at 
50% of VO2max, in 20 minute bouts, separated by five min rest periods and continued 
until 3% body weight was lost. No fluids were ingested by subjects during exercise. To 
estimate whole body fluid loss, nude body weight was obtained pre-exercise and every 20 
min during cycling; subjects undressed and towel dried in a screened area within the heat 
chamber prior to each weighing.  
Following the exercise-induced dehydration protocol, subjects moved to a 
thermoneutral room (22°C) for a 60 min recovery period. Subjects were provided ad 
libitum a carbohydrate-electrolyte replacement beverage with 20 mmol Na+ (Gatorade, 
Pepsico, Purchase, NY).  Due to CF subject complaints following the exercise-
dehydration protocol presumably from substantial sweat NaCl losses, CF were also 
provided ad libitum salty foods (e.g. potato chips, salty crackers) beginning at 30 minutes 
of recovery and these subjects remained an additional 60 min for monitoring of blood 
[Na+] prior to departure.   
 
3.3.3.3.  Measurements 
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VO2 and RER were obtained five min prior to the end of every 20 min exercise 
stage by open-circuit spirometry using a PARVO Medics TrueOne 2400 Metabolic 
Measurement System (Parvo Medics, Inc., Salt Lake City, UT). HR was measured via 
telemetry (Polar Electro Inc., Woodbury, NY) and recorded every five min. Core 
temperature was monitored using an ingestible temperature sensor (CoreTemp, HTI 
Technologies Inc, Palmetto, FL) and recorded every 20 min. RPE with a 15 point Borg 
Scale 124 was recorded at the end of each 20 min exercise stage. Rating of perceived thirst 
using a 10 mm Visual Analog Scale (VAS) was obtained prior to and every 20 min 
during cycling and every 10 min during the post-exercise recovery.  Without giving 
specific rehydration instructions to subjects, post-exercise volume of beverage ingested 
ad libitum was also recorded.  
 
3.3.3.4.  Regional Sweat Analysis 
Sweat was collected with the modified Brisson method 20 using a collection pouch 
constructed with impermeable Parafilm (7 cm x 8 cm) (American Can Co., Greenwich, 
CT) and Opsite wound dressing (10 cm x 14 cm) (Smith & Nephew Inc., Largo, FL). The 
sweat collection site was the scapular region, an accessible area that correlates well to 
whole-body sweat concentrations for [Na+] and [Cl-] 18. The skin of the scapula was 
cleaned with alcohol, deionized water, and sterile gauze, and air dried before application 
of the collection pouch. Sweat was aspirated from the collection pouch every 20 min 
during cycling. Sweat [Na+], [Cl-], and [K+] were measured in triplicate using a chemistry 
analyzer (Nova 5, Nova Biomedical, Waltham, MA).  Frequent removal of accumulated 
sweat minimized electrolyte leaching from the epidermal layer into the sweat sample. 
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Stable sweat [K+] values throughout the collection time points provided evidence that this 
potential source of error was minimal 126. 
 
3.3.3.5.  Blood and Urine Analysis 
A forearm vein was cannulated with subjects in a supine position, and following 
12 min in a sitting position, a resting blood sample was drawn.  Blood samples were also 
drawn every 20 min during the cycling protocol, and following the 60 min post-exercise 
recovery period. For most CF subjects, additional recovery period samples were drawn at 
30 min, 90 min, and 120 min. The catheter was kept patent with a sodium heparin 
lockflush solution between samplings. Following removal of a ~1.5 mL waste sample, 
venous blood was drawn into an EDTA-treated test tube and immediately analyzed for 
hemoglobin (Hb) (HemaCue AB, Angelholm) and hematocrit (Hct) (microhematocrit 
centrifugation). Blood was centrifuged at 3,000 rpms for 10 min and plasma was stored at 
-20° C.  Plasma hormone assays were performed by an outside laboratory (Yerkes 
Biomarkers Core Lab, Emory University). Plasma samples corresponding to baseline 
(0%), 1.5%, and 3.0% dehydration were analyzed using commercially-available 
radioimmunoassay kits for aldosterone (ALDO) (Diagnostic Systems Laboratories, 
Beckman Coulter, Webster, TX), and angiotensin II (AngII) (American Laboratory 
Products Company, Windham, NH), and a commercially-available enzyme immunoassay 
kit for arginine vasopressin (AVP) (Assay Designs, Ann Arbor, MI). At all collection 
times, a venous sample was also drawn into a serum separator tube, allowed 30 to 60 min 
to clot, and centrifuged at 3,000 rpms for 10 min. Urine was collected pre- and post-
exercise, and during the 60 min recovery period to assess volume, specific gravity 
(handheld refractometry), and [electrolytes]. There was no urine output during exercise 
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except for one SS subject. In this case, the urine output during exercise was included in 
the post-exercise urine volume. Urine and serum [Na+], [K+], and [Cl-] were measured 
with a Nova5 chemistry analyzer (Nova Biomedical, Waltham MA). Serum was also 
measured for osmolality via freeze point depression method (MicroOsmette Precision 
Systems, Natick, MA). 
 
3.3.3.6.  Calculations 
Total body water (TBW) loss was estimated from body weight loss. Total sweat 
loss was calculated from net change in body weight assuming that water loss due to 
respiration was negligible 156. Electrolyte losses in sweat and urine were calculated by 
multiplying the volume lost by the [electrolyte] of each 157. Cation loss was calculated as 
[([Na+] + [K+])sweat  x volumesweat } + {([Na
+] + [K+])urine  x volumeurine ]. Free water 
(FW) loss was calculated as TBW loss – (cation loss x 2)/serum Osmopre. The ratio of 
FW loss to TBW loss describes the nature of the dehydration challenge (isotonic vs. 
hypotonic) and determines how the TBW loss is shared by the different body fluid 
compartments 79 158.  The relative change in plasma volume (%ΔPV) was calculated from 
changes in Hb and Hct 159.   
 
3.3.4.  Statistical Analysis 
The sample size required to obtain a measurable effect on serum [Na+] and 
osmolality was estimated based on previously published research with eight cyclists 
exercising in the heat that resulted in varied sweat electrolyte loss 6. Using G Power 160, 
for a power of 0.9 and a minimum effect size of 0.75, comparisons between 16 subjects 
was considered adequate. Analysis of variance with repeated measures (ANOVA-RM) 
was used to assess differences among groups for physiological responses across 
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dehydration levels 0 to 3.0%, or across recovery time points. One-way Analysis of 
variance (ANOVA) was used to assess differences among groups for variables not 
expressed over progressive dehydration or time such as subject characteristics, pre-test 
measures, and change relative to baseline for variables measured post-exercise or post-
recovery. When a significant main effect for group was observed, post-hoc analyses 
(Tukey) were performed to identify between-group differences. Association of sweat 
[Na+] with serum osmolality, actual and predicted serum [Na+], % ΔPV, and hormone 
responses; and association of physiological responses to dehydration with ad libitum 
drinking volume were analyzed with Pearson product-moment correlation. All statistical 
testing was conducted using SPSS (ver. 17.0, Chicago, IL).  An α level of 0.05 was used 
to indicate statistical significance.  All values are presented as mean (± SD). 
 
 
3.4.  Results 
 
3.4.1.  Sweating Characteristics and Responses 
Sweating-related characteristics are presented in Table 3.2. Control, SS, and CF 
had similar exercise time, TBW loss, and percent body weight loss (3% dehydration) 
achieved at the termination of exercise. There was no difference among groups in sweat 
rates (SR) expressed relative to kg of body mass, or as absolute values ( 0.9 ± 0.2 L/hr for 
Control, 1.0 ± 0.3 L/hrfor SS, and 0.7 ± 0.2 L/hr for CF). Sweat electrolytes presented in 
Table 3.2 reflect an average for all values obtained during the entire exercise protocol.  
As an expected outcome based on the subject recruitment procedure, sweat [Na+] and [Cl-
] were significantly higher for CF and SS compared to Control (p<0.001) and also higher 
for CF compared to SS (p<0.001). Consistent with reports in the literature 2 64, CF sweat 
[K+] was also significantly higher compared to both non-CF groups (p= 0.04 vs. Control 
and p=0.02 vs. SS); moreover, Control sweat [K+] did not differ from SS (p=0.941).  
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There was no significant relationship observed for SR and sweat [Na+] (r = -0.278, 
p=0.223). Sweat [Na+] and [Cl-] increased with progressive dehydration as expected and 
consistent with the literature 6. There was a trend (p=0.074) for sweat [Na+] to increase 
more in Control compared to CF.  Sweat [Na+] was significantly and inversely associated 
with free water (FW) loss (Fig 3.1, r = -0.991, p<0.001). Calculated FW loss relative to 
kg of BW was significantly lower for SS (12.2 ± 3.0 ml/kg BW), p<0.001) and CF (1.1 ± 
2.5 ml/kg BW, p<0.001) compared to Control (21.7 ± 1.8 ml/kg BW). FW loss in CF was 
also significantly less than SS (p<0.001). This was also observed when FW loss was 
expressed as a percentage of ΔTBW (Fig 3.2).  
 
 
Table 3.2: Mean (±SD) characteristics for Control, non-CF salty sweaters (SS), and 
cystic fibrosis (CF) subjects (n=21) for exercise time to achieve 3% dehydration, total 
body water (TBW) loss relative to body weight (BW), free water loss relative to BW, 
sweat rate (SR) relative to BW, change in SR by 3% compared to 1% dehydration final 
exercise stage, sweat electrolytes concentration (indicated by brackets), and change in 
sweat electrolytes by final exercise stage. Percent change values are calculated relative to 
values at 1.0% dehydration. * Significantly > Control, # CF significantly > SS (p<0.05).  
 
 Control SS CF 
Exercise time (min) 122.5 ± 16.7 125.7 ± 27.6 130.0 ± 24.5 
TBW loss (ml/kg) 33.8 ± 3.3 32.1 ± 2.8 30.4 ± 2.8 
Free water loss (ml/kg) 21.7 ± 1.8   12.2 ± 2.9 *         1.1 ± 2.5 * # 
Sweat Rate (ml/min/kgBW) 212.8 ± 32.5 215.8 ± 58.0 183.7 ± 29.0 
% Change in SR    -2.8 ± 12.5    -1.6 ± 22.9    -1.3 ± 20.2 
Sweat [Na+] (mmol/L) 43.7 ± 9.9      91.0 ± 17.3 *    132.6 ± 6.4 * # 
% Change in Sweat [Na+]   14.2 ± 9.5   8.2 ± 7.4   4.2 ± 5.0 
Sweat [Cl-] (mmol/L) 41.9 ± 6.9      84.1 ± 18.0 *       127.0 ± 12.1 * #
% Change in Sweat [Cl-]   16.1 ± 9.7   9.4 ± 8.9   6.2 ± 4.7 
Sweat [K+] (mmol/L)   4.7 ± 0.5      4.4 ± 0.3 *         7.4 ± 3.3 * # 
% Change in Sweat [K+]    -4.2 ± 8.8      2.0 ± 10.3    1.8 ± 8.1 
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3.4.2.  Blood Responses 
Serum osmolality increased during exercise but was not different across groups at 
the same relative level of dehydration (p=0.589) (Fig 3.3a); however, the increase in 
serum osmolality was significantly less in CF (p= 0.015) at 1.5 through 3.0% dehydration 
and in SS (p=0.034) at 3% dehydration compared to Control (Fig 3.3b).  A significant 
relationship (r = -0.756, p<0.001) was determined between sweat [Na+] and change in 
osmolality (Fig 3.4a), such that individuals with the highest sweat [Na+] had smaller 
change in osmolality. 
 
 
y = -0.68x + 95.0
Pearson r = -0.991 *



























Fig. 3.1: Relationship between regional sweat sodium concentration (indicated by 
brackets), and change from baseline in free water relative to change in total body water 
(ΔFW/ΔTBW) incurred by exercise in the heat to 3% body weight loss (3% dehydration) 
for Control subjects (blue squares) with ‘typical’ sweat [Na+], non-CF salty sweaters 
(orange squares), and CF subjects (red squares) with phenotypically very high sweat 




































Fig. 3.2: Mean ± SD Free water loss relative to total body water loss (ΔFW/ΔTBW) 
incurred by exercise in the heat to 3% body weight loss (3% dehydration) for Control 
subjects (blue) with ‘typical’ sweat sodium concentration (indicated by brackets), non-CF 
salty sweaters (SS, orange), and CF subjects (CF, red) with phenotypically very high 
















































Fig. 3.3: Mean ± SD serum osmolality (A) and change (Δ) in serum osmolality (B) 
relative to percent body weight loss (percent dehydration) during exercise in the heat for 
Control subjects (blue) with ‘typical’ sweat sodium concentration (indicated by brackets), 
non-CF salty sweaters (SS, orange), and CF subjects (CF, red) with phenotypically very 

















































Fig. 3.4: Relationship between regional sweat sodium concentration (indicated by 
brackets), and change from baseline in serum osmolality incurred from exercise in 
the heat to 3% body weight loss (3% dehydration) for Control subjects (blue 
squares) with ‘typical’ sweat [Na+], non-CF salty sweaters (orange squares), and 
CF subjects (red squares) with phenotypically very high sweat [NaCl].  
 * p <0.001, n=19. 
 
 
Serum [electrolytes] during progressive dehydration and recovery are presented in 
Figures 3.5a-c. Control and SS had similar pre-exercise serum [Na+] (p=0.370) but CF 
had higher pre-exercise serum [Na+] than SS (p=0.023) (Fig 5a).  However, CF 
developed lower serum [Na+] than Control (p=0.022) at 2.5% dehydration and CF values 
remained lower throughout exercise (p=0.003) and recovery (p=0.013) (Fig 3.5a). Net 
change in serum [Na+] was significantly less for CF (2.88 ± 1.7 mmol/L)  
y = -0.10x + 18.7






















































































































Fig. 3.5: Mean ± SD serum Na+ concentration (indicated by brackets) (a), serum [Cl-] (b), 
and serum [K+] (c), relative to percent body weight loss (percent dehydration) during 
exercise in the heat and at 60 min recovery for Control subjects (blue) with ‘typical’ 
sweat, non-CF salty sweaters (SS, orange), and CF subjects (CF, red) with phenotypically 
very high sweat [NaCl]. * CF significantly less than Control,   p < 0.05, # CF 




compared to SS (6.3 ± 1.0 mmol/L, p=0.001) and Control (7.5 ± 1.0 mmol/L, p<0.001), 
and less for SS compared to Control (p=0.05).  
Unlike serum [Na+], serum [Cl-] was not different among groups at baseline 
(p=0.356) (Fig 3.5b). Serum [Cl-] in CF did not increase with progressive dehydration as 
it did for SS and Control, but decreased significantly below baseline at 2.5% dehydration 
(p=0.04)  and was significantly lower (p=0.031) than Control after 1.5% dehydration (Fig 
3.5b) .  SS serum [Cl-] was significantly lower than Control at 2% dehydration (p=0.05) 
and remained lower throughout exercise (p=0.03)(Fig 3.5b).  Net change in serum [Cl-] 
was less for CF (-0.8 ± 0.7 mmol/L) compared to both SS (p<0.001), and Control 
(p<0.001), and less for SS (2.9 ± 1.5 mmol/L) compared to Control (4.9 ± 1.0 mmol/L, 
p=0.02). 
There was no difference among groups in serum [K+] from 0-3% dehydration or 
following recovery (Figs 5c).  There was also no difference in net change (pre- to post- 
exercise) in serum [K+] among groups.  
There was no difference among groups in baseline Hb (13.4 ± 1.6, 14.1 ± 1.3, and 
14.6 ± 1.4 g/dL) or Hct (40.3 ± 1.5%, 41.8 ± 1.9% for SS, 43.7 ± 3.7% for Control, SS, 
and CF, respectively). Percent reduction in plasma volume (PV) across progressive 
dehydration was significantly greater in CF (p=0.04) and SS (p=0.03) compared to 
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Control (Fig 3.6) and post-exercise percent loss in PV was significantly greater in CF 
(p=0.03) and SS (p=0.01) compared to Control. There was a significant relationship (r= 
0.53, p=0.02) between sweat [Na+] and post-exercise relative change in plasma volume 
(Fig 3.7) such that those with higher sweat [Na+] had greater relative loss of plasma 
































Fig. 3.6: Mean ± SD % change in plasma volume relative to body weight loss (percent 
dehydration) during exercise in the heat for Control subjects (blue) with ‘typical’ sweat 
Na+ concentration (indicated by brackets), non-CF salty sweaters (SS, orange), and CF 
subjects (CF, red) with phenotypically very high sweat [Na+],  * CF significantly < 
Control,  p < 0.05, * SS significantly < Control,   p < 0.05. 
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y = -0.07x - 11.7
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Fig. 3.7: Relationship between regional sweat sodium concentration (indicated by 
brackets), and relative change in plasma volume (%ΔPV) incurred from exercise in the 
heat to 3% body weight loss (3% dehydration) for Control subjects (blue squares) with 
‘typical’ sweat [Na+], non-CF salty sweaters (orange squares), and CF subjects (red 
squares) with phenotypically very high sweat [NaCl]. * p <0.05, n=19 
 
 
SS had significantly higher plasma [AVP] at baseline than Control (p=0.042) 
(Table 3.3) and remained higher during progressive dehydration and at 60 min of 
recovery (p=0.034) (Table 3.3). A significant positive relationship was determined for 
non-CF subjects between sweat [Na+] and plasma [AVP] at baseline (r = 0.707, p=0.007), 
post-exercise (r = 0.616, p<0.05), and recovery (r = 0.712, p=0.006) indicating in healthy 
subjects higher sweat [Na+]  was associated with higher AVP . There were no differences 
among groups for change in plasma [AVP] relative to baseline across dehydration and at 
60 min recovery (p=0.619), nor was there any relationship observed between change in 
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plasma [AVP] at any collection points and sweat [Na+]. Higher recovery plasma [AVP] 
was associated with greater fluid retention in recovery (calculated as % of ingested fluid 
that was not diuresed by 60 min post-exercise) (r = 0.605, p = 0.049) and post-exercise 
urine volume (r = -628, p=0.029) when considering only non-CF subjects. Pre- to post-
exercise increase in plasma [AVP] was associated with greater dehydration-induced 
change (% increase) in sweat [Na+] (r = 0.490, p=0.046) and smaller dehydration-induced 
reduction (% decrease) in SR (r = -.656, p=0.003).  
There were no differences among groups in either plasma [AngII] or ALDO at 
baseline, 1.5% and 3.0% dehydration, or after 60 min post-exercise recovery (Table 3.3). 
There were also no differences among groups in change in plasma [AngII]  or ALDO 
relative to baseline at any sample points.   
 
 
Table 3.3: Mean (±SD) in Control, non-CF salty sweaters (SS), and cystic fibrosis (CF) 
subjects (n=19) for plasma hormone concentration (indicated by brackets) of arginine 
vasopressin ([AVP]), angiotensin II ([angII]), and aldosterone ([ALDO]) at baseline 
(pre),in samples corresponding to 1.5% and 3% dehydration, and at 60 min post-exercise 
(post-recovery). * Significantly > Control (p<0.05). 
 
 
Pre 48.1 ± 13.0 81.8 ± 36.5 * 72.0 ± 33.9 
1.5% 54.7 ± 18.1 88.9 ± 37.6 * 73.7 ± 28.4 
3.0% 58.6 ± 19.5 101.2 ± 41.9 * 79.4 ± 21.3 
[AVP] 
Post-recov. 47.4 ± 16.4 83.0 ± 31.9 * 71.6 ± 30.7 
Pre 7.7 ± 5.3 5.5 ± 2.9 9.5 ± 8.9 
1.5% 25.8 ± 20.4 25.5 ± 9.6 55.6 ± 72.9 
3.0% 54.9 ± 54.9 47.0 ± 23.2 90.5 ± 91.6 
[AngII] 
Post-recov. 12.8 ± 6.3 16.4 ± 18.5 31.9 ± 40.8 
Pre 151.3 ± 55.9 135.0 ± 47.7 160.5 ± 68.8 
1.5% 496.5 ± 181.8 482.9 ± 159.9 692.0 ± 387.5 
3.0% 753.1 ± 271.7 845.1 ± 407.1 957.3 ± 481.3 
[ALDO] 
Post-recov. 338.4 ± 90.1 455.9 ± 263.1 454.4 ± 195.7 
 
CF SS Control 
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3.4.3.  Physiological Responses 
 Relative exercise intensity (%VO2max) was similar among groups as designed 
(51.9 ± 2.5% for Control, 51.2 ± 2.6% for SS, and 52.6 ± 2.8% for CF).  Mean HR across 
the dehydration protocol were higher for CF compared to Control and SS (p=0.013), but 
mean %HRpeak, was not different (p= 0.223) among groups (72.5 ± 4.4%  for Control, 
72.8 ± 5.6%  for SS, and 77.6 ± 7.1% for CF) and increased with progressive dehydration 
(by 8.1 ± 4.4 % for Control, 9.1 ± 4.7% for SS, and 6.1 ± 5.4 % for CF). There was no 
difference among groups in core temperature relative to dehydration level. Final core 
temperature was 38.4 ± 0.3 for Control, 38.1 ± 0.2 for SS, and 38.1 ± 0.4°C for CF and 
increased similarly among groups (net change of 1.5 ± 0.5 for Control, 1.4 ± 0.6 for SS, 
and 1.0 ± 0.2 °C for CF).  There was no difference (p=0.696) in RPE between groups 
relative to dehydration across the exercise protocol. RPE increased with progressive 
dehydration similarly among groups (2.1 ± 1.7 for Control, 2.8 ± 2.2 for SS, and 2.9 ± 1.4 
for CF). 
 
3.4.4.  Thirst Response  
 
Thirst ratings via VAS are presented in Fig 8. Pre-exercise thirst rating was 
similar among groups (1.4 ± 1.2 for Control, 1.9 ± 0.9 for SS, and 1.2 ± 0.5 for CF). 
There was no difference among groups in thirst rating relative to dehydration across the 
exercise protocol (p=0.956) or recovery (p=0.724) (Fig 8).  Net change in thirst ratings at 
3% dehydration from pre-exercise values was also similar (p=0.298) among groups (5.95 
± 1.6 for Control, 5.33 ± 1.9 for SS, and 6.72 ± 0.9 for CF). There was also no difference 
among groups (p=0.798) in level of dehydration at the thirst rating of ‘4’, which is 
anchored by the descriptors, “a little thirsty” and “moderately thirsty” on the 10  
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cm VAS rating scale. Mean (± SD) % dehydration at the “4” rating was 1.20 ± 0.8% for 
Control, 1.11 ± 0.9 for SS, and 1.39 ± 0.2 for CF.   
Post-exercise thirst rating (at 3% dehydration) tended to be higher in subjects with 
greater increase in plasma [AVP] (r = 0.413, p=0.08, n=16).  Greater post-exercise thirst 
was also seen with greater dehydration-induced elevation in serum osmolality, but only 
for the control group (r = 0.833, p=0.01, n=8).  For SS, there was a tendency for greater 
post-exercise thirst to occur in those with greater increase in plasma [AngII] (r = 0.670, 
p=0.14, n=6).    
 Individual responses for CF subjects are presented along with mean (± SD) 
volume of fluid ingested ad libitum (normalized by BW) for the three groups during 
recovery in Figure 9. There was no difference between Control and SS in beverage 
volume (p=0.70); however, CF drank significantly less compared to Control and SS when 
expressed in absolute volume in mL (p=0.018 vs. Control, 0.017 vs. SS) and relative to 




























Fig. 3.8: Mean ± SD rating of thirst relative to percent body weight loss (percent 
dehydration) during exercise in the heat for Control subjects (blue) with ‘typical’ sweat, 
non-CF salty sweaters (SS, orange), and CF subjects (CF, red) with phenotypically very 
high sweat [NaCl].  
 
 
Greater early ad libitum drinking (volume relative to BW, consumed in the first 30 min of 
recovery) was related to greater dehydration-induced elevation of serum [Cl-] (r = 0.645, 
p= 0.003), and [Na+] (r = 0.491, p=0.03), and lower sweat [Na+] (r = - 0.490, p=0.024),  
and [Cl-] (r = -0.474, p=0.030). These relationships did not persist for healthy subjects 
(n=14) when CF subjects were eliminated from the analysis (p>0.05). Mean % 
dehydration (relative to pre-exercise?) at 60 min post-exercise despite ad libitum fluid 
ingestion in recovery was similar (p=0.137) for Control( 0.3 ± 0.9%), SS ( 0.3 ±  0.4%) 
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Fig 3.9: Mean ± SD cumulative volume of sports beverage consumed during ad libitum 
drinking of recovery period following exercise in the heat to 3% body weight loss 
(dehydration) for Control subjects (blue squares) with ‘typical’ sweat, non-CF salty 
sweaters (SS, orange squares), and CF subjects (CF, red squares) with phenotypically 
very high sweat [NaCl]. Individual data for CF is also shown (solid lines). * CF 




3.4.5.  Recovery Blood and Urine Responses 
 
Individual and mean serum [electrolyte] responses during 60 min recovery (and 
an extended recovery period of 120 min for CF) are presented in Figure 3.9. Net change 
in serum [Na+] from baseline at 60 min recovery (Fig 10a) was significantly less for CF 
compared to Control (p=0.009) and compared to SS (p=0.005). Following the 60 min 
recovery, serum [Na+] was significantly lower (p=0.013) for CF (141.9 ± 0.6 mmol/L) 
compared to Control (145.1 ± 1.9 mmol/L), but not different from SS (144.0 ± 1.8 
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mmol/L, p=0.129). There were no CF or SS subjects that exhibited hyponatremia (<135 
mmol/L). Serum [Cl-] at 60 min recovery was also significantly lower (p=0.032) for CF 
(103.9 ± 1.3 mmol/L) compared to Control (107.6 ± 2.5 mmol/L) but not compared to SS 
(105.6 ± 2.3 mmol/L).  Serum osmolality at 60 min recovery was not different (p=0.886)  
(290.5 ± 11.1 mOsm/kgH2O for Control, 287.5 ± 8.3 mOsm/kgH2O for SS, and 288.3 ± 
3.6 mOsm/kgH2O for CF) and was different from baseline in Control (p<0.001), but not 
for CF (p=0.082) or SS (p=0.167).  
 Recovery values for %ΔPV at 60 min post-exercise following ad libitum fluid 
ingestion were still below baseline for all groups, and the differences across groups did 
not reach significance (p=0.685) (-3.7 ± 11.1% for Control, -3.6 ± 8.3% for SS, and -5.5 
± 3.6% for CF). Mean (± SD) plasma volume restoration (difference between %ΔPV 
post-exercise and %ΔPV following recovery at 60 min post-exercise) was greater 
(p<0.05) in SS (15.2 ± 4.1) than Control (10.6 ± 3.6), but not CF (13.8 ± 4.7, p=0.847); 
and the difference in plasma volume restoration between CF and Control did not reach 
significance (p= 0.178).  
 Effects of exercise-induced dehydration to 3% body weight loss and ad libitum 
drinking in the subsequent 60 min recovery period on urine [electrolytes], specific 
gravity, and volume are presented in Table 3.4. CF and SS appeared to concentrate their 
urine less during recovery compared to Control in terms of change in [electrolytes] and 
USG; and CF appeared to retain less of what was a significantly smaller fluid intake, 





Table 3.4: Mean (±SD) 60 min post-exercise recovery values in Control, non-CF salty 
sweaters (SS), and cystic fibrosis (CF) subjects (n=21) for percent change in urine Na+ 
concentration (indicated by brackets) relative to baseline (pre), and relative to immediate 
post-exercise values (post-ex), urine volume, urine specific gravity (USG), fluids 
ingested ad libitum relative to body weight (BW), and percent of fluids ingested during 
ad libitum drinking not lost in urine (% of ingested fluid retained), n=21. * < Control and 
SS (p<0.05). 
  
60 min Recovery 
Variable 
Control SS CF 
% Δ urine [Na+] 
from pre 
210.4 ± 144.7 108.6 ± 97.1 49.6 ± 90.6 
% Δ urine [Na+] 
from post-ex 
74.3 ± 50.6 36.1 ± 53.2 15.4 ± 62.1 
Urine Vol (mL) 54.3 ± 27.8 58.7 ± 52.9  90.7 ± 79.1 
USG 1.022 ± 0.004 1.021 ± 0.007 1.020 ± 0.010 
Fluid ingested 
(mL/kgBW) 
27.2 ± 8.3 26.7 ± 3.7  19.0 ± 4.2 * 
% of ingested  
fluid retained 
96.7 ± 2.1 96.7 ± 3.6 92.6 ± 5.4 




3.5.  Discussion 
The present study provided a novel comparison of physiological responses to 
prolonged exercise in the heat among groups with varying NaCl loss in sweat. A key 
focus was the physiological impact of high sweat [NaCl] on factors known to drive thirst 
during progressive dehydration. The most salient finding was that perceived thirst was 
not differentially affected by sweat [NaCl] during exercise, despite our observation that, 
as hypothesized, the hyperosmolality that typically accompanies progressive dehydration 
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was attenuated in subjects with greater sweat NaCl loss. Since increased blood osmolality 
is a potent stimulator of thirst in humans 75-78, similar perceived thirst with differential 
osmotic stimuli in our subjects with high sweat [NaCl] (Fig 3.3) was unexpected. We also 
did not anticipate that the loss of PV relative to dehydration would be greater in subjects 
with high sweat [NaCl] (Fig 3.6). Interestingly, despite similar post-exercise thirst 
ratings, we observed less ad libitum fluid ingestion for individuals with CF compared to 
healthy subjects during the post-exercise recovery period.  
That thirst sensitivity was largely unaffected by high sweat NaCl loss in CF and 
SS may be attributed to the well-documented redundancy in the control mechanisms for 
thirst drive (i.e. osmolality and relative volume of fluid within the vascular space in the 
face of moderate dehydration) 77 161 77 161.  The fact that drinking behavior subsequently 
was different in CF subjects also suggests that thirst sensitivity (Fig 3.8) is not 
unidimensional (based solely on hyperosmolality or on hypovolemia). The greater loss of 
PV relative to dehydration (Fig 3.6) likely impacted thirst sensitivity in SS and CF as it is 
recognized that a reduction in extracellular fluid (ECF) volume, such as incurred with PV 
loss (although believed to be secondary 162) also serves as a signal for thirst. A 10% 
decrease in plasma volume induces an animal to drink voluntarily 77. In humans, the 
hypovolemic threshold for stimulation of thirst is a body water loss of ~0.8% 73 76. While 
all subjects experienced similar relative TBW loss in the dehydration protocol of this 
study (3% of body weight), maintenance of fluid within the vascular space with 
dehydration was less in SS and CF (Fig 3.6). Therefore, while their hyperosmotic 
stimulus for thirst was less, SS and CF subjects may have had a greater hypovolemic 
stimulus relative to dehydration which maintained thirst sensitivity similar to Control. 
 70
Supporting the notion that thirst sensitivity in individuals with high sweat [NaCl] may 
rely additionally on hypovolemic stimuli, while individuals with more ‘typical’ 
hypotonicity of sweat rely primarily on hyperosmotic stimuli, post-exercise thirst was 
related to dehydration-induced elevation in serum osmolality only within Control, and 
there was a tendency post-exercise thirst to relate to dehydration-induced elevation of the 
(primarily hypovolemic hormone) plasma [AngII] only within SS. 
Congruent with the observation that relative loss of PV was greater in SS and CF 
compared to Control (Fig 3.6), a strong positive relationship was determined for sweat 
[Na+] and reduction in PV with dehydration (Fig 3.7). These observations are somewhat 
counterintuitive, for it might be expected that Controls, with greater fluid lost relative to 
solute in sweat and greater increases in blood osmolality, would also demonstrate greater 
PV loss. However, the opposite finding was observed: SS and CF did not maintain PV 
with dehydration as well as Control. This might be explained by differences in osmotic-
driven shifts between fluid compartments. With exercise-induced dehydration (loss of 
hypotonic body water via sweating), fluid is drawn from the intracellular fluid (ICF) 
compartment into the vascular space of the ECF compartment, along an osmotic gradient 
determined primarily by the [NaCl] of the blood, in order to maintain circulating blood 
volume 156 158 163. Nose et al. 79 a strong positive correlation between dehydration-induced 
change in blood osmolality and change in ICF volume (r = 0.738, p<0.02), and between 
sweat [Na+] and dehydration-induced change in ECF volume (r = 0.804, p<0.01). This 
led them to conclude that the [Na+] in sweat dictates the osmotic gradient that determines 
directional fluid shifts between compartments with dehydration whereby the greater the 
sweat [Na+], the greater the loss in ECF relative to total body water loss 79.  We cannot 
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report changes in ICF and ECF that occurred in our subjects because the calculations 
require measurement of initial total plasma volume. However, given that the relationships 
observed for sweat [Na+] with FW loss (fig. 3.1), and change in blood osmolality with 
FW loss (r = 0.719, p<0.01), are remarkably similar to those reported by Nose et al. 79 for 
subjects dehydrated to 2.3% body weight loss via exercise, it is likely, too, that a reduced 
shift from the ICF to ECF compartment occurred in SS and CF compared to Control due 
to the diminishing effect of high sweat [NaCl] on osmotic pressure to maintain fluid in 
vessels with dehydration.  Since the major determinant of osmolality is NaCl levels in the 
blood, the finding of smaller dehydration- induced change in serum [Na+] and [Cl-] in SS 
and CF subjects with greater sweat [NaCl] loss is congruent with the finding of 
attenuated dehydration-induced increase in osmolality in these subjects as well.  
The tendency for post-exercise thirst rating (at 3% dehydration) to be higher in 
subjects with greater dehydration-induced increase in plasma [AVP] is consistent with 
the well-documented dipsogenic effect of this hormone 72 73 123. A primary driver of 
hyperosmotic thirst, AVP is released from the posterior pituitary gland in response to cell 
shrinking (from loss of ICF), mediated through activated, volume-depleted osmoreceptor 
cells in the pre-optic anterior hypothalamus 77. It was anticipated that the plasma AVP 
response to dehydration might be blunted in SS and CF since their dehydration-induced 
relative hypernatremia and hyperosmolality (Figs 3.3, 3.5), and thus secondary 
dehydration of the ICF compartment, was less. Further, it was anticipated that the 
dipsogenic hormone most sensitive to loss of PV, angiotensin II 162, might demonstrate a 
more pronounced rise in SS and CF with greater relative PV loss over dehydration (Fig 
3.6). However, change in plasma [AVP] and plasma [AngII] with dehydration was not 
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different among groups (Table 3.3). The absence of differential effect of sweat [NaCl] on 
dipsogenic hormone response may be explained by the significant cross-talk that is 
known to exist between hormones of the hyperosmotic and hypovolemic thirst pathways 
77. For instance, peripherally-administered AngII can stimulate AVP release by acting on 
circumventricular organs or directly on the pituitary, and intracranial AngII can also 
cause vasopressin release 162 164.  
Understanding human thirst is important since it has been recognized that the 
drive to drink in humans may be blunted in healthy individuals under certain 
physiological, psychological, and environmental stresses (i.e. athletic competition, cold) 
71 87; as well as diseases such as CF, where involuntarily dehydration during exercise has 
been speculated due to an impaired hyperosmotic trigger for thirst 83 151.  Our results on 
CF subjects are especially novel because serial blood sampling during the dehydration 
and recovery protocols permitted drinking behavior differences in this population to be 
related to measured changes in hydration and electrolyte balance.  CF responses were 
particularly unique because it appears that despite the predicted attenuated 
hyperosmolality, perceived thirst per during moderate dehydration was not affected; 
however, when presented with fluids during recovery, drinking behavior was different. 
While sustaining similar relative TBW loss (3% dehydration), CF subjects ingested 30% 
less fluid ad libitum during recovery than non-CF (even the saltiest of sweaters). Such 
‘involuntary dehydration’ in our CF subjects is inconsistent with the similar perceived 
thirst ratings throughout exercise that mirrored the other non-CF groups, but consistent 
with the behavior observed by other investigators 83 151 for CF children during ad libitum 
fluid replacement following exercise. This suggests that volitional fluid intake for CF is 
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particularly influenced by factors other than just TBW loss, such as the unique challenge 
to [NaCl] balance that they incur with prolonged sweating. Volitional drinking may have 
been additionally repressed in CF by the hypotonicity of the recovery beverage provided 
([Na+] = 20 mmol). As present evidence indicates, CF ingestion of the sports drink during 
recovery elicited marked decreases relative to baseline in serum [Na+] and, to a greater 
extent, [Cl-], within 30 min (Fig 3.10).  It is possible that the relatively rapid decrease in 
serum [NaCl] for CF may have served to inhibit appetite for the hypotonic beverage 
provided. Consistent with this, it is known that drinking is also controlled by sodium 
appetite 158 162. Osmoreceptors in the organum vasculosum of the lamina terminals 
(OVLT) and subfornical organ (SFO) responsible for eliciting thirst also trigger one’s 
taste for salt 158 162. In addition to input from osmoreceptors, recent evidence in rats 
suggest that specialized salt sensors with Na+ sensitive channels, Nax, are also located on 
cells of the circumventricular organs and may also contribute to fluid intake behavior 
independently of plasma osmolality 165. While not well characterized in humans, Nax in 
laboratory rats is thought to function by responding to a rise in [Na+] of the cerebrospinal 
fluid and, via efferent projections to the pre-optic anterior hypothalamus, stimulate AVP 
release as well as signal other motor effector regions of the brain 165.  Analysis of 
drinking patterns in rats with experimentally-induced hypertonic vs. hypotonic 
hypovolemia suggests that avoidance of salt imbalance is given preference over 
stimulation of fluid intake for blood volume restoration, with inhibitory signals 
originating from both the gastrointestinal tract and circumventricular organs involved in 
this response 156 161 162 166 167.  Similar to that demonstrated repeatedly in animal models, 
the reduced ad libitum fluid ingestion in CF may reflect physiological cues directed at 
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preservation of salt balance over volume restoration. To illustrate this, individual serum 
[Na+] and [Cl-] responses during recovery are plotted for the CF subjects (Fig 10 a, b). 
Unique to CF, post-exercise serum [Cl-] was reduced, and post-exercise serum [Na+] was 
minimally increased, relative to baseline. By 30 minutes into the recovery period of ad 
libitum drinking, serum [Na+] dropped below pre-exercise values for four CF subjects, 
and to pre-exercise value for another. Serum [Na+] continued to decrease and by 60 
minutes reached values 2-5 mmol/L below pre-exercise.  At 90 min into recovery, serum 
[Na+] was below pre-exercise values for all five CF subjects and by 2 hours post exercise 
remained lower for 3 of the subjects, equaled pre-exercise value for one subject, and in 
one was not measured.  
At the start of the recovery, serum [Cl-] was below pre-exercise values for all but 
one of the CF subjects. By 30 minutes into the recovery period, serum [Cl-] had dropped 
further for all CF subjects, between 3 and 4.5 mmol/L below baseline. Serum [Cl-] 
continued to fall for 4 of the subjects, and remained unchanged in one of the subjects, so 
that by 60 minutes reached between 3 and 7 mmol/L below baseline.  By 90 min into 
recovery, serum [Cl-] was still below baseline for all five CF subjects and by 2 hours post 
exercise remained lower relative to baseline for 4 of the subjects; and for one was not 
measured.    
Illustrating the potential importance of a strategy aimed at preservation of salt 
balance over volume restoration, CF subjects CPE and SWH had the lowest ad libitum 
drinking volume relative to BW during the first 40 min of recovery (Fig 3.9) and by 60 
min had the smallest remaining deficit relative to baseline in serum [Na+] (Fig 3.10 a) and 

































































Fig. 3.10: Mean ± SD change relative to baseline in serum Na+ concentration (indicated 
by brackets) (a), and [Cl-] immediately following exercise in the heat to 3% body weight 
loss (dehydration), and during ad libitum drinking of subsequent recovery period, for 
Control subjects (blue squares) with ‘typical’ sweat, non-CF salty sweaters (SS, orange 
squares), and CF subjects (CF, red squares) with phenotypically very high sweat [NaCl]. 
Individual data for CF is also shown (solid lines). * Significantly < Control, p< 0.05 for 
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Fig. 3.11: Individual CF subjects’ ad libitum salt intake during 30-60 min of recovery 
period following exercise in the heat to 3% body weight loss (dehydration). One CF 
subject and all non-CF subjects were not presented with salty foods during recovery.   
 
 
of clinical hyponatremia (<135 mmol/L), it is tempting to speculate how much lower CF 
serum [Na+] and [Cl-] might have continued to fall without provision for ad libitum salty 
snacks along with sports drink replacement after 30 min in recovery (Fig. 3.11). 
During progressive dehydration, there was no effect of sweat electrolytes on other 
physiological responses (e.g. SR, thermoregulation) important for safety during exercise 
in the heat. SR decreased and core temperature increased similarly for Control, SS and 
CF.  While an increase in blood osmolality is believed to be a signal for the reduction in 
sweating sensitivity associated with dehydration during exercise in the heat 88 168-170, 
sweating sensitivity was not different in the saltiest sweat groups with attenuated rise in 
serum osmolality.  However, analogous to the dual control mechanism for fluid intake, 
hyperosmolality and hypovolemia jointly contribute to sweating inhibition in order to 
preserve fluid and electrolyte balance during prolonged thermoregulatory demand 171 172. 
 77
Therefore, even though SS and CF may have experienced less hyperosmotic inhibition of 
sweating with dehydration, this may have been offset by their reduced maintenance of PV 
potentially contributing to a greater hypovolemic inhibition of sweating as dehydration 
progressed during exercise.  
 
3.6.  Summary and Practical Recommendations 
In summary, unique findings from this study were that despite smaller FW loss 
and attenuated serum hyperosmolality with dehydration, thirst perception was not 
differentially affected in individuals with high sweat [NaCl] loss during exercise (both 
healthy and CF patients).  The greater relative PV losses with dehydration observed in 
these individuals may serve as compensatory input to drive thirst in the absence of a 
strong hyperosmotic signal. Thirst drive appears to be appropriately maintained despite 
large variability in human sweat electrolyte loss, particularly when considering that 
drinking behavior in the CF patients following dehydration appeared to be more 
responsive to serum [NaCl] compared to body fluid loss. With a sweat concentration of 
salt nearly isotonic to blood, CF did not experience hyponatremia during exercise (2-2.5 
hr duration) with moderate dehydration when not ingesting fluids, but ad libitum fluid 
replacement with a hypotonic sports beverage resulted in a fall in blood [NaCl] below 
pre-exercise values.  These data suggest that CF should approach replacement with 
hypotonic fluids cautiously and ingest salt to minimize risk of electrolyte deficiency 
during recovery from prolonged exertion-related sweating.  The ‘involuntary 
dehydration’ reported to occur in CF 83 151, and observed in the recovery phase of this 
study, may reflect physiological cues directed at preservation of salt balance over volume 
restoration. Further research is needed to identify optimal fluid and electrolyte 
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replacement strategies for this population who, clearly, can gain the health-related 








4.1. Inter-individual Differences in Sweat Composition Related to Channel Function 
A major conclusion from the present work is that differences in CFTR channel 
expression may be a mechanism underlying variability in human eccrine sweat [NaCl]. 
However, as discussed in chapter 2, the magnitude of difference from Control for sweat 
[NaCl] did not match the magnitude of difference from Control in CFTR expression for 
the excess salty sweaters studied. For instance, sweat [NaCl] was ~ 100% greater in non-
CF salty sweaters (SS) compared to Control while CFTR expression was only ~ 25% 
less. Further, appearance of CFTR in the sweat duct lumen only explains ~ 21% of the 
variance in sweat [Na+] in non-CF subjects. This discrepancy suggests that another 
mechanism beyond CFTR quantity as assessed by immunostaining may contribute to 
inter-individual differences in sweat [NaCl] in healthy individuals. However, it is also 
possible that the method used to quantify immunostaining intensity of channel expression 
(via selected cross-sectional sections along variable locations within the sweat duct) 
could not completely capture relative deficiencies in total sweat duct channel proteins. 
Use of immunofluorescence staining to evaluate channel expression is less ideal than 
more quantifiable methods of total channel protein expression, such as immunoblotting. 
However, it was not possible to obtain sufficient protein in the 4 to 6 sweat glands 
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homogenized from 4 mm skin biopsies to perform immunoblotting experiments, and 
increasing the size of human tissue biopsied  was also not a reasonable option.   
In addition to quantification limitations imposed by immunhistochemistry 
methods, it was not possible to assess with these methods how differences in overall 
channel function may also contribute to inter-individual differences in sweat [NaCl]. To 
evaluate cell physiology (i.e. channel function) and cell morphology unaffected by 
questions of tissue preservation, the study of living sweat gland cells would be preferred.  
Studies of living sweat gland cells have been largely limited to model systems such as 
cultured cells and isolated ductal segments 47 49-51 60 173 174. Unfortunately, morphological 
and functional observations that are secondary to cell culturing may be difficult to 
distinguish from physiological ones. For instance, if primary cultures of sweat duct cells 
obtained from isolated ducts would have been used to compare epithelial transport among 
subjects in the present study, known quantitative differences in active Na+ flux in cells of 
primary culture compared to intact sweat ducts 175 may have led to flawed interpretations 
regarding the relationship between channel function and sweat [NaCl]. It was originally 
proposed that channel function would be compared among subjects using 
electrophysiology experiments on isolated sweat ducts. Measurement of size-relative 
currents of individual cells in isolated ducts could have allowed evaluation of differences 
in membrane transport among the three subject groups attributed to differences in 
maximal activation capability of electrolyte channels present. Unfortunately this 
electrophysiological data was not collected because the split tubule technique required for 
patch clamping experiments on apical membrane cells was determined not possible on 
isolated ducts. The split tubule model used extensively in the study of renal tubules 176-178 
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has never been performed with sweat gland tubules. In our hands, sweat ducts were 
successfully isolated from skin samples but the thick basement membrane, two-cell 
thickness, and frequently-closed lumen of the tubule segments (Fig 4.1) made it difficult 








Fig. 4.1: Cut end of a microdissected sweat duct from a pilot subject skin biopsy viewed 
under light microscopy. Arrows indicate uniquely ductal characteristics. Original 




An alternative method to determine differences in channel function among individuals 
with varying sweat [NaCl] is the tubule microperfusion technique 12 55 62. This technique 
is performed routinely in sweat glands but only by a relatively few number of laboratories 
because it is technically difficult and requires specialized instrumentation of an 
electrophysiology ‘rig’ in order to achieve and maintain tubule perfusion. Another 
limitation of the tubule microperfusion method that may make it less useful for 
comparisons between tissues is that it measures transepithelial currents representing the 
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summation of activity from thousands of cells lining the duct, rather than from a single 
cell, and therefore inter-individual differences in total measured current could be 
confounded by inter-individual differences in tubule morphology.   
It is always a concern that experimental systems employing isolated cells and 
isolated tubules do not accurately represent the in vivo situation because they lack 
interactions with blood vessels, nerves, extracellular matrix, and other supporting tissues. 
An alternative to the microperfusion technique that may, in the future, facilitate the study 
of living sweat duct channel function in its native environment is the application of 
multicolor two-photon intravital microscopy to biopsied human skin samples. Two-
photon fluorescence depends on the simultaneous absorption of two photons of light, and 
fluorescence excitation occurs only at a focal point where the density of illuminating 
photons is highest 179. Fluorescence generated in two-photon microscopy can be collected 
without a confocal aperture, which allows measurement of fluorescence generated deep 
in light-scattering tissue that is otherwise immeasurable 180.  Two-photon microscopy has 
been recently adapted for use in explanted organs of living laboratory animals, for 
instance to obtain three dimensional information regarding the complex organization of 
the kidney 181 182. Two-photon intravital microscopy such as that providing in vivo and 
real time study of epithelial transport in nephrons 181 has not been performed in living 
humans for obvious reasons. However, it may be possible to extend this technique to 
living human tissue. Intact sweat glands distributed throughout biopsies of human skin 
were noted to stay alive and capable of epithelial transport for several days following 
removal when maintained in cold lactate Ringers with glucose. Viability of sweat glands 
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was evidenced by secretion of Neutral Red into the ductal lumen within ten minutes 





Fig. 4.2: Viability of the eccrine sweat gland of a 4 mm punch biopsy removed from a 
pilot subject 2 days earlier, shown (a) embedded in fat globule and dermis of intact skin 
plug, and (b) in an isolated sweat duct,. Neutral Red added to bath is taken up into the 
gland and secreted into the ductal lumen (dark red stripe) within 10 min. Original 




isolated gland (Fig 4.2b). Therefore, future work may be directed at novel adaptation of 
two-photon fluorescence microscopy to permit ‘ex vivo’ study of the living human sweat 
gland maintained in its physiological dermal environment. Two-photon microscopy 
employing intracellular probes like acytoxylmethyl esters could be used to measure inter-
individual differences in ductal epithelial electrolyte transport, pH regulation, calcium 
flux, and the like. Skin samples containing sweat glands are readily accessible and 
require a minimally invasive punch biopsy to obtain. If two-photon ex vivo microscopy 
can be successfully adapted for use in fresh skin biopsies, the technique could be 
particularly useful in therapeutics research, such that directed at improving CFTR 
expression and function in CF epithelium. Strength of such an approach is that it would 
permit the simultaneous study of inter-individual differences in drug response 
mechanistically (e.g. ductal transport) and symptomatically (e.g. sweat composition) in 
order to improve target specificity. 
 
4.2.  Aquaporin Expression in Human Sweat Duct 
It is possible that inter-individual differences in sweat [NaCl] could also be 
attributed to differences in expression of other membrane transport proteins in sweat 
gland epithelium. Membranous aquaporins of principal cells forming the collecting duct 
in renal tubules are largely responsible for dictating urine concentration by regulating the 
reabsorption of water through this tight epithelium of the nephron 183. Differences in 
collecting duct aquaporins have been implicated in pathology related to fluid and sodium 
management such as hypertension 184.  It is possible that inter-individual differences in 
expression of aquaporins could contribute to inter-individual variability in sweat [NaCl]. 
However, as discussed in chapter two, evidence for the presence of aquaporins in the 
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human sweat duct is not convincing. In the one study of aquaporin expression to date that 
included human sweat glands 142, no quantitative assessment is provided and only a single 
fluorescence image of an immunostained gland is shown. It is not clear from the poorly 
visualized cell morphology in that image if the aquaporin staining was along the lumen of 
the ductal versus the secretory portion of the sweat gland. Therefore, a follow-up 
experiment should investigate the expression of aquaporins in the human sweat duct, and 
the relationship to [NaCl] in excreted sweat. This could be achieved with the same 
protocol employed in the present study except with the use of primary antibodies directed 
at aquaporins instead of at ENaC and CFTR when immunostaining cryosections. AQP5 
appears to be expressed in the secretory coil of mice and rat paw sweat glands 142 so 
AQP5 may be the most logical aquaporin to investigate first in human glands.   
 
4.3.  Differences in Hormonal Regulation of Sweat Duct Transport 
 
Interestingly, basal plasma vasopressin concentrations ([AVP]), as well as levels 
measured in the plasma after 1.5% and 3% dehydration and recovery, were unexpectedly 
elevated for the non-CF subjects with high salt sweat examined in the present study. 
Elevated AVP has been suggested as a potential contributing mechanism to exercise-
induced hyponatremia based primarily on retrospective investigation of post-exercise 
blood [AVP] in athletes receiving medical attention for symptomatic hyponatremia 185 186. 
In individuals susceptible to the condition dubbed the ‘syndrome of inappropriate 
secretion of AVP (SIADH)’, an inability to rapidly excrete relative fluid excess when 
excessive fluid intake is coupled to high [Na+] losses is thought to cause and/or sustain 
low serum [Na+] 70 93 95 185-187.  It has been assumed that the elevated post-exercise [AVP] 
measured in these athletes is a consequence of failure to appropriately suppress AVP but 
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it is not clear in these retrospective studies if baseline AVP and thus net change in AVP 
was also different for these athletes.  Higher baseline plasma [AVP] (that remained 
higher through dehydration and recovery) was observed in SS compared to Control of the 
present study, but change in plasma AVP across graded dehydration and following 
recovery was similar. If, in these SS, recovery plasma [AVP] were to have been 
examined without consideration of the higher starting values, it may have been assumed 
that they, like the hyponatremic athletes in the retrospective studies 185 186, had 
inappropriate secretion of AVP relative to their Control counterparts. Since greater 
sodium loss in sweat is associated with risk for hyponatremia, it is likely that many of the 
hyponatremic athletes in the retrospective studies were indeed ‘salty sweaters’ like SS in 
this study.     
While the cause for the higher plasma [AVP] in SS is not apparent, it is possible 
that increased plasma [AVP] could have contributed to the greater [NaCl] of sweat in 
these individuals. AVP acts on aquaporin channels to increase water absorption across 
renal epithelium 184. As discussed above, the mere presence of aquaporins in the human 
sweat duct needs to be established prior to suggesting that differing vasopressin levels 
may be related to sweat [NaCl]. However, increased vasopressin could contribute to 
greater sweat [NaCl] in non-CF salty sweaters via another mechanism. In vitro 
vasopressin addition to rat collecting tubules transiently increases activity of the enzyme 
hydroxysteroid dehydrogenase type II (HSD2) 188. The enzyme 11 beta-hydroxysteroid 
dehydrogenase type II (11 beta HSD2) confers specificity on mineralocorticoid receptors 
(MR) by inactivating glucocorticoids. In eccrine sweat ducts, MR is present on 
basolateral membranes and 11 beta HSD2 is present on luminal membranes 189. Recently 
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reported in Hypertension 190, HSD2 activity was found to be partially deficient in isolated 
sweat ducts from individuals with essential hypertension as compared to normotensives. 
This indicates that MR, 11 beta HSD2 and vasopressin could play an important role in the 
regulation of sweat duct Na+ absorption and is a topic ripe for further investigation.  
Further, it would be interesting to investigate if the elevated plasma [AVP] found in the 
high salt sweaters of this study may have resulted in chronic, elevated in vivo exposure to 
vasopressin at the duct and subsequently increased luminal HSD2 activity, as it is known 
to do in other absorptive epithelium 188. Increased HSD2 would decrease Na+ 
reabsorption across duct and could be a contributing mechanism for the greater salt losses 
in sweat for individuals with elevated vasopressin.  
 
4.4.  Colocalization of CFTR and ENaC in Human Eccrine Sweat Duct 
A functional link between CFTR and ENaC has been suggested based on 
evidence from electrophysiological and biochemical methods in heterologous expression 
systems 191. Their interaction in native tissue is not clearly defined but is implicated in the 
pathophysiology of CF 192. One proposed mechanism is a direct protein-protein 
interaction between CFTR and ENaC, suggested based on evidence from 
electrophysiological 100 193, FRET 194, yeast-two-hybrid 195, and co-immunoprecipitation 
196 methods in heterologous expression systems. However, the overexpression required 
for these methods to work in mammalian cells can produce interactions between the 
channel proteins that are neither entirely specific nor physiologic. In this respect, 
investigation of a potential CFTR-ENaC relationship under conditions of endogenous 
channel expression is favored, but complicated by the large quantity of tissue required to 
obtain measurable membrane protein levels. While tangential to the primary aims of this 
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thesis work, in order to provide a novel characterization of the physical proximity of 
CFTR and ENaC in a native absorptive epithelium, immunostained cryosections of 
subjects’ biopsied tissues were additionally examined under laser confocal microscopy 
(Olympus Microscopes, Melville, NY). Photomicrographs of immunofluorescence were 
captured using FluoView software (Olympus) and colocalization of ductal 
immunoreactivity corresponding to CFTR and ENaC was quantified using ImageJ 
(National Institutes of Health, Bethesda, MD).  Some sections were treated with a 
polyclonal antibody against an epitope near the N-terminus of the α1 subunit of 
Na+K+ATPase, which contains the binding sites for ATP and cations (N-15, sc-16041, 
Santa Cruz Biotechnology, CA). Na+K+ATPase is located primarily on the basolateral 
and apical membrane of the outer duct cell and the basolateral membrane of the inner 
duct cell 41. Therefore co-staining for Na+K+ATPase with CFTR served as a negative 
control for colocalization.  
Similar to epifluorescence microscopy (chapter 2), immunostaining visualized 
under confocal microscopy marked abundant CFTR (green) and ENaC (red) as expected 
in the ductal portion of the sweat glands (Fig 3). Staining was primarily localized to the 
luminal membrane for both channels, but immunoreactivity for ENaC was additionally 
observed across the entire duct. Quantification of preliminary images indicated that 
lumen-specific staining was significantly greater for CFTR (by 195.3 ± 32%, p<0.001) 
and ENaC (by 98.2 ± 38%) compared to staining across the entire duct. CFTR and ENaC 
in preliminary images were also well-associated in the duct (R=0.48, p<0.05) but show 
even stronger correlation in the lumen (R= 0.69, p<0.01). Immunostaining for 














Fig. 4.3 a and b: Immunofluorescence staining of the eccrine sweat gland reabsorptive 
duct in 6 µm cryosections of biopsied human skin under laser confocal microscopy. Anti-
αENaC labeling with H-95 (column 1, red) and anti-CFTR labeling with M3A7 (column 
1, green) revealed immunoreactivity particularly corresponding to the luminal plasma 
membranes. Overlay of images from column 1 and 2 demonstrates where 
immunoreactivity to CFTR and ENaC was colocalized (column 3, yellow). Tubules 
without luminal staining in image ‘a’ are secretory coil. Original magnification 40x. 
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luminal ductal cells, the apical and outer membrane of outer ductal cells, and largely 
absent at the apical membrane of inner ductal cells (Fig 4). While image analysis and 
quantification of Na+K+ATPase localization with CFTR has not yet been performed, no 





Fig. 4.4: Overlay image of immunofluorescence staining of eccrine sweat gland 
reabsorptive ducts in 6 µm cryosection of biopsied human skin under epifluorescence 
microscopy. Anti-α1-Na+K+ATPase labeling with N-15 (red) revealed immunoreactivity 
particularly corresponding to the basolateral plasma membranes while anti-CFTR 
labeling with M3A7 (green) stained lumen. Original magnification 40x. 
 
 
While not a primary aim of the present investigations, immunofluorescent 
staining of subject biopsies additionally visualized under confocal microscopy has 
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provided a novel demonstration of localization of CFTR and ENaC in a native absorptive 
epithelium. These preliminary data suggest that colocalization of CFTR and ENaC is 
particularly rich along what operates as the reabsorptive epithelium of the duct. Their 
striking physical proximity at this principal site of transepithelial NaCl transport speaks 
to the functionality of the CFTR-ENaC physical association and lends support to a 
potential direct protein interaction between these two membrane transport channels. 
Continued experiments are planned in order to fully investigate this interesting 
preliminary finding. These follow-up experiments are 1) to perform co-immunostaining 
in sweat ducts for two subunits of ENaC, α and β, as a positive control for colocalization; 
2) to additionally quantify colocalization in ~10 confocal images from each of  ~ 6 
different subjects’ immunostained sweat ducts (CF and non-CF) to build upon the current 
data set.  
 
4.5. Indirect Evidence for Acute Regulation of Sweat Duct Reabsorption 
Sweat [Na+] and [Cl-] increased as expected with progressive dehydration for all 
subjects participating in the present study (chapter 3). Differences were observed among 
subject groups in dehydration-induced change in electrolyte composition.  Since rate of 
sweating and ductal electrolyte reabsorption are thought to be related 12 13; it is important 
to note that sweat rate (SR) did not differ among groups and therefore differences in 
dehydration-induced change in sweat [NaCl] were not confounded by a varied SR 
response among groups. It is interesting that differences among Control, SS and CF in 
dehydration-induced elevation in sweat [Na+] and [Cl-] (Table 2, chapter 3) are similar to 
the between-group differences noted in dehydration-induced elevation in serum [Na+] and 



























































Fig. 4.5: Mean ± SD change in serum Na+ concentration (indicated by brackets) (a), and 
serum [Cl-] (b), relative to baseline following exercise in the heat to 3% body weight loss 
(dehydration) for Control subjects (blue) with ‘typical’ sweat [NaCl], non-CF salty 
sweaters (SS, orange), and CF subjects (CF, red) with phenotypically very high sweat 
[NaCl]. * Significantly < Control (p < 0.05), # CF significantly < SS (p<0.05). 
 
 




 [Na+] and [Cl-] with dehydration occurred in Control, then SS, then CF.  However, it is 
curious that the magnitude of increase in sweat [Na+] and sweat [Cl-] with dehydration 
did not match the magnitude of increase in serum [Na+] and serum [Cl-] with 
dehydration. For example, in Control, sweat [Na+] increased by 13% while serum [Na+] 
increased by ~ 3%.  In SS, sweat [Na+] increased by 8% while serum [Na+] increased by 
only 2%. Morgan et al.6 noted a similar mismatch in the magnitude of change in serum 
[Na+] and sweat [Na+] with acute dehydration. This observation led them to be among the 
first to suggest that the sweat gland might be acutely regulated by hormonal or 
sympathetic input to adjust Na+ reabsorption in response to a stimulus such as elevated 
serum electrolytes.  The concept of an acutely regulated sweat gland is not consistent 
with the traditional assumption that the increase in sweat electrolyte loss (e.g. with 
dehydration) is primarily a function of increased blood electrolytes delivered to the sweat 
gland due to relatively greater loss of fluid in sweat relative to electrolytes since sweat is 
typically quite hypotonic to sodium chloride compared to plasma concentration. If the 
increase in sweat [NaCl] with dehydration were to be simply due to blood levels 
increasing (e.g. more Na+ in = more Na+ out), then the percent change incurred with 
dehydration in sweat [Na+] and serum [Na+] should be nearly identical. The discrepancy 
in magnitude of change can be explained, however, if the sweat duct’s ion transport 
activity is considered potentially capable of acute regulation via alterations in 
transmembranous channel function. It is not known if hyperosmotic stimuli can signal for 
an acute compensatory down regulation of NaCl absorption in sweat duct epithelium as it 
does in renal and gut epithelium.  However, the human eccrine sweat gland is well-
evolved to provide copious sweating for cooling during even prolonged thermoregulatory 
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challenges 36.  Furthermore, the sweat duct is equipped for acute regulation with 
epithelial transport proteins responsive to changes in intracellular and extracellular 
milieu. As evidence of regulation in the sweat duct that works on a simple negative 
feedback loop, Reddy and Quinton (2006) demonstrated using tubule microperfusion that 
intracellular [K+] helps to regulate NaCl influx to prevent the massive entry that could 
otherwise lead to cell swelling and destruction. They determined that relatively low 
basolateral K+ conductance in non-transporting cells helps to maintain higher intracellular 
[K+], which results in the tonic inhibition of endogenous phosphatase dephosphorylation 
of CFTR. Then, at the onset of the sweating when primary sweat first enters into the 
lumen of the duct, there is a massive rapid NaCl influx into the cell through ENaC and 
CFTR down their concentration gradients. This large NaCl influx increases 
Na+K+ATPase activity which serves to maintain concentration gradients. The activated 
CFTR results in an increased K+ conductance at the basolateral membrane for the exit of 
K+ from the ductal cells. The lowering of intracellular K+ serves as a feedback 
mechanism whereby the tonic inhibition of phosphatases is reduced, thus decreasing the 
PKA phosphorylation of CFTR 197 which reduces the channel activation and the entry of 
Cl- and Na+ from the lumen into the cell. Slowing the entry of Cl- and Na+ from the 
lumen into the ductal cell lowers the K+ conductance at the basolateral membrane,  and 
eventually a new steady state is reached where the influx balances the outflux to prevent 
the cell from swelling and bursting.  
Another example of acute regulation of electrolyte transport in a different 
secreting and absorbing epithelium, increased cytosolic [Na+] or [Cl-] results in an acute 
down-regulation of luminal ENaC in salivary duct epithelium 198. It has not been 
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investigated if increases in serum [Na+] or [Cl-] may increase cytosolic [Na+] or [Cl-] of 
sweat duct cells and if this in turn is able to down-regulate luminal ENaC in ductal 
epithelium. However, supporting the concept of an acutely regulate-able sweat gland 
during prolonged thermoregulation, Buono et al. 199 determined that sweat Na+ 
reabsorption rate increases proportionately less than Na+ secretion rate with increases in 
sweat rate, and suggested that the inhibitory effect of decreasing cytosolic pH on ENaC 
could mechanistically explain this observation.  If reabsorption across the sweat duct is 
acutely regulated in response to serum concentration changes, then in the present study 
where serum osmolality was observed to rise more in response to dehydration in Control 
due to their greater free water (FW) loss, the response to this stimulus would be greater 
signaling for reduction of NaCl reabsorption across the sweat duct epithelium. It follows, 
then, that the greatest magnitude of dehydration-induced increase in sweat [Na+] and [Cl-] 
is in Control. The fact that in CF subjects the percent change in dehydration-induced 
elevation in sweat [Na+]  and serum [Na+]  were curiously more similar to each other than 
they were in the non-CF subjects serves to reinforce the concept of an acutely regulate-
able sweat duct, in a pathway that directly or indirectly involves the chloride channel 
CFTR. Without much functioning CFTR at the sweat duct, CF are quite possibly not able 
to perform the suggested regulation to the degree that non-CF are capable.  While no 
group’s sweat or serum [K+] changed significantly, it is interesting that the mean change 
in [K+] is in the opposite direction in non-CF subjects. This makes physiological sense 
because K+ moves in the opposite direction of Na+ and Cl- during epithelial transport and 
SS and Control had a relatively larger (and possibly intentional) increase in sweat [NaCl] 
with dehydration.   
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While indirect evidence provided by the present study suggests that the sweat duct 
may actually decrease NaCl reabsorption in order to attenuate hyperosmolality during 
progressive dehydration, more research is needed to determine if and how the sweat duct 
is capable of acutely regulating ductal reabsorption during prolonged thermoregulatory 
sweating. Taking the notion of an acutely regulate-able sweat gland even further, it was 
suggested in a recent paper that the sweat gland may actually serve as an integral 
regulator of fluid and [Na+] balance during exercise 141, possibly though AVP response, 
based on relationships observed for post-exercise plasma [AVP], and sweat and urine 
[Na+]. One limitation to this study, however, is that the authors do not report change 
values for plasma [AVP] so it is difficult to assess true hormone ‘response’. It is possible 
that baseline AVP was also related to sweat [Na+] in their subjects, as it was for the non-
CF subjects in the present study, which would indicate that the relationship they were 
observing was not truly an acute regulatory response per se. Clearly, future experiments 
are needed to investigate potential mechanisms at the level of the gland for acute sweat 
gland regulation. Such experiments could employ sweat duct tubule microperfusion or ex 
vital microscopy of sweat ducts in skin to assess acute changes in channel behavior in 
response to ligands (e.g. aldosterone and vasopressin), and in response to changes in 
intracellular and extracellular environments (e.g. pH, salinity).  
 
4.6.  Sweat Cl- is Hypertonic to Serum Cl- in CF 
Consistent with compromised ductal NaCl reabsorption, sweat [Na+] in CF was 
higher than both non-CF groups and near-isotonic to serum. Sweat [Cl-] in CF was also 
higher than both non-CF groups and the difference between sweat [Cl-] and sweat [Na+]  
was smaller for CF subjects, as other researchers have reported with cholinergic- 
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stimulated sweat testing 2 54 56. Interestingly, sweat [Cl-] was not only higher than non-CF 
but was hypertonic to serum in all CF subjects. Using in vitro sweat induction in isolated 
glands, Sato and Sato 64 demonstrated that, relative to the extracellular bath, [Na+] and 
[K+] in the primary sweat produced by the secretory coil is nearly isotonic, but [Cl-] is 
actually hypertonic, in both CF and non-CF tissue. Therefore, in the case of severely 
limited ductal Cl- reabsorption, such as that in CF, it is not unphysiological for the [Cl-] 
of the final excreted sweat to be measured higher than serum levels. Other factors may 
also contribute to the hypertonic sweat [Cl-] in CF, such as greater net Cl- transport out of 
the ductal cell into the lumen secondary to abnormal activity of a putative luminal HCO3
-
/Cl- exchanger 200, particularly if HCO3
- management is faulty in the CF sweat gland as it 
is in other CF epithelia. Potentially prompting greater HCO3
-/Cl- exchanger activity, 
sweat [HCO3
-] may have been higher in CF subjects. Indeed, the anion gap (Na+ + K+ - 
Cl-), thought to approximate HCO3
- + lactate 201, was significantly greater in CF sweat 
than non-CF sweat, as others have shown in pilocarpine-stimulated sweat 56 202. Future 
research should investigate how the sweat gland handles HCO3
- and the role that CFTR 
may play in this process.  
 
4.7.  Predicting Changes in Serum Na+ and Susceptibility to Exercise-induced 
Hyponatremia 
 
Exercise-induced hyponatremia (serum [Na+] < 135 mmol/L) at endurance events, 
such as the marathon or ultradistance triathlon, is most commonly attributed to ingestion 
of hypotonic fluids in excess of fluid loss, ‘overdrinking,’ and is associated with post-
event weight gain 93. While not as common, hyponatremia may also occur in conjunction 
with dehydration, particularly in longer, ultraendurance events 26 70 94 203 or military 
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operations. This ‘hypovolemic hyponatremia’ is presumably from excessive salt 
depletion via sweating and not from overdrinking, according to a recently-developed 
quantitative model 26. This model, based on a equation developed by Kurtz and Nguyen 
204, predicts post-exercise serum [Na+] on the basis of changes in the mass balance of 
cations Na+, K+, and water.  The high sweat [Na+] in CF and also found in many healthy 
individuals may present a greater risk for the development of hyponatremia during 
prolonged activity in the heat 26 70 95 96. One example is the case reported by Smith et al. in 
1995 of a British soldier who developed hyponatremia during desert marches on two 
occasions and was subsequently confirmed to have elevated sweat electrolytes and 
homozygous CF mutations 205.  In the present study, examination of actual and calculated 
predicted change in serum [electrolytes] with progressive dehydration in individuals with 
salty sweat compared to those with normal sweat [NaCl] was additionally performed to 
indicate whether or not hyponatremia may be possible and predictable in some 
individuals (i.e. those with excess salt loss in sweat) over the duration of ultraendurance 
events in the absence of overdrinking.    
Predicted post-exercise serum [Na+] was calculated for each subject according to 
Nguyen and Kurtz 204:  Post-Exercise Serum [Na+] = {[(Initial serum [Na+] + 23.8) * 
initial TBW + 1.03 ΔE] / (initial TBW – TBW loss)} – 23.8.  Initial TBW assume = 0.73 
of fat-free mass 206. Individually-calculated predicted serum [Na+] values were compared 
to actual values with paired t-tests and association of sweat [Na+] with actual and 
predicted serum [Na+] was analyzed with Pearson product-moment correlation (SPSS, 
ver. 17.0, Chicago, IL).   
 
4.7.1.  Predicted vs. Actual Post-Exercise Serum [Na+]  
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The difference between calculated (predicted) post-exercise serum [Na+] and 
measured (actual) values for all subjects was (mean ± SD) -1.5 ± 1.2 mmol/L. The 
discrepancy between actual and predicted values for post-exercise serum [Na+] was not 
different among the three groups (p=0.333).  Mean ± SD for difference between actual 
and predicted values for post-exercise serum [Na+] was  -1.12 ± 1.2 mmol/L for Control 
(p=0.03), -2.16 ± 1.2 mmol/L for SS (p=0.01), and -1.55 ± 1.4 mmol/L for CF (p=0.06).   
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Fig. 4.6: Relationship between predicted (calculated) serum sodium concentration [Na+] 
and actual (measured) serum [Na+] following exercise in the heat to 3% body weight loss 
(3% dehydration) for Control subjects (blue squares) with ‘typical’ sweat [Na+], non-CF 
salty sweaters (orange squares), and CF subjects (red squares) with phenotypically very 
high sweat [NaCl]. Predicted value was calculated using equation by Kurtz and Nguyen 
204 which predicts post-exercise serum [Na+] on the basis of changes in the mass balance 




A significant (p <0.001) relationship was determined between measured post-exercise 
serum [Na+] and predicted values (Fig 6).  This relationship (y=0.96x + 6.9, Pearson 
r=0.92) was similar to that reported by Baker et al. (y = 0.84x + 23, Pearson r=0.90) for 
subjects following prolonged running in the heat with ending dehydration levels of 0, -2, 
and -4% body weight loss. 207. The linear regression’s non-zero positive y-intercept, and 
the mean negative value for difference between predicted and measured post-exercise 
serum [Na+],  indicates that the equation slightly over predicted Na+ losses for our 
subjects.  There are a number of possible explanations for this. First, an overestimation of 
[Na+] lost in sweat could have resulted from collection artifact, such as that proposed by 
Weschler due to electrolyte leaching from the stratum corneum 126, or a discrepancy 
between regional and whole body sweat electrolyte loss 21. The low and extremely 
consistent values for sweat [K+] measured in our sweat sampling across the 80 to 160 min 
dehydration protocol indicate that electrolyte leaching as a source of sample artifact is not 
likely 126.  It is possible that sweat collected from the scapular region was slightly higher 
in [Na+] than reflected in whole body sweat. While whole-body washdown is the criterion 
method to determine whole body sweat Na+ losses 22 208, it was not practical for use in 
this protocol. Stofan et al. recently put forth an equation, y=0.67x-2.56, for correction of 
regional samples obtained from the back to reflect whole body losses 209. When this 
equation is used to correct individual subjects’ sweat [Na+] values prior to use in the 
Nguyen-Kurtz equation, the gap between predicted and actual post-exercise serum [Na+] 
almost completely closes (mean ± SD difference = -0.20 ± 1.4 mmol/L for Control, -0.42 
± 1.2 mmol/L for SS, 0.72 ± 1.2 mmol/L for CF, and 0.03 ± 1.3 mmol/L for the whole 
group). A final possible explanation for the small discrepancy between predicted and 
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actual post-exercise serum [Na+] is the mobilization of osmotically-activated Na+ from 
exchangeable internal stores 93, a notion put forth by Noakes et al. as a potential 
mechanism determining susceptibility to hyponatremia under conditions of overdrinking. 
The existence and identity of such an internal store, and its potential function in 
regulating extracellular fluid space electrolyte balance during prolonged sweating have 
not yet been elucidated.  
 
4.7.2.  Risk for Exercise-Induced Hyponatremia- Evaluating Actual and Predicted  
 Post-Exercise Serum [Na+]  
 
The relationship between sweat [Na+] and actual (open circles) and predicted 
(closed circles) post-exercise serum [Na+] is shown in Fig 7. Actual and predicted post-
exercise serum [Na+] values with 3% dehydration did not fall into hyponatremia range (< 
135 mmol/L, shaded region Fig 7) for any of the subjects following their ~ 2 hr 
dehydration cycling protocol. Using the Nguyen-Kurtz equation 204 in the model 
proposed by Montain et al. 26 to predict post-exercise values for serum [Na+] if all body 
water loss were to be exactly replaced by water (0% dehydration) indicated that one CF 
and one SS subject would have become hyponatremic (closed squares, Fig 4.7) at the 
same exercise duration. Calculating post-exercise serum [Na+] values at 3% dehydration 
but doubling each subject’s total exercise time (to closer reflect marathon and other 
ultraendurance events finishing times)  indicated that one CF subject would have become 
hyponatremic (closed diamonds, Fig 4.7). Finally, post-exercise serum [Na+] values 
calculated for both double the exercise duration and with all body water loss exactly 
replaced by water  (0% dehydration) indicated that all subjects (n=11) with sweat [Na+] > 
60 mmol/L would have become hyponatremic (closed triangles, Fig 4.7).  As expected 
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with an exercise protocol of dehydration and relatively short duration (~ 2 hrs), no 
subjects developed exercise-induced hyponatremia. However, examination of the 
relationship between sweat [Na+] and predicted post-exercise serum electrolytes when 
each subject’s own exercise duration is extended two-fold (4-5 hr typical of ultra-
endurance events) predicts that hypovolemic hyponatremia may be possible in extremely 



































Fig. 4.7: Actual and predicted post-exercise serum [Na+] with 0% dehydration and with 
3% dehydration, for two different total exercise durations. Open circles and black trend 
line: actual values at 3% dehydration, r= 0.761. y = -0.042x + 151.6. Closed circles and 
green trend line: predicted values at 3% dehydration, r = 0.798, y = -0.045x + 150.2. 
Actual and predicted lines were not different. Closed diamonds and brown trend line: 
predicted values at 3% dehydration and 2x the subject’s exercise duration, r= 0.925, y = -
0.093x + 149.7. Closed squares and purple trend line: predicted values at 0% dehydration 
(all sweat loss replaced 100%with water), r=0.693, y = -0.03x + 140.3. Closed triangles 
and light blue trend line: predicted values if 0% dehydration (all fluids exactly replaced 
with water) and 2x the subject’s exercise duration, r=0.871, y = -0.080x + 139.7. 
Hyponatremia is indicated by yellowed area.  
 





of dehydration and overdrinking, predicted serum [Na+] calculated for a condition of 
euhydration (0% body weight loss/gain , water exactly replaces fluid volume loss) 
predicts that one CF and one SS subject would have become hyponatremic at the end of 
their exercise testing session.  Furthermore, when calculated again for a condition of 
euhydration but at an exercise duration arguably more representative of a typical 
recreational marathon finish time (~ 4 to 5 hrs), all CF and SS subjects were predicted to 
be in the range of clinical hyponatremia when water intake exactly replaces fluid volume 
loss. It is important to note that none of these predictions factor in electrolyte replacement 
of any kind and would not likely represent what most competitors would practice during 
endurance exercise.  These data suggest that exercise-induced hyponatremia appears to be 
possible in the absence of overdrinking within the typical exercise duration required to 
finish a marathon (4-5 hours) for CF and healthy individuals with sweat [Na+] above ~ 65 
mmol/L. Future experiments should investigate the impact of sweat [NaCl] loss on fluid 
and electrolyte balance during exercise in the heat with ad libitum vs. regimented fluid 
and/or electrolyte replacement. In conjunction with ad libitum vs. regimented fluid and 
electrolyte replacement, actual and predicted during- and post-exercise serum [Na+] could 
be assessed for incidence and potential risk of exercise-induced hyponatremia.  
 
4.8. Self-assessment of Sweat Composition 
Findings from the present study, as well as from other investigations 26, suggest 
that individuals with high sweat [Na+] may be at greater risk for exercise-induced 
hyponatremia during prolonged exercise in the heat, such as military operations or 
performance of ultra-distance marathons and triathlons. Since measurement of 
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thermoregulatory sweat [electrolytes] requires specialized collection and a chemistry 
analyzer, it is often not practical in field settings. Therefore, it important to understand 
how well individuals are able to assess their own sweat electrolyte losses to formulate 
personal fluid and electrolyte replacement strategies during prolonged endurance events. 
It has been suggested that it may be possible to subjectively identify individuals with high 
sweat salt [NaCl] from complaints of a salty taste of sweat in their mouth or eye irritation 
when sweat drips into their eyes; or from visible salt stains on clothing worn during 
prolonged exertion in the heat 210. To date, there have been no studies to investigate the 
validity of such assessment. To address this need, subjects in the present study completed 
a brief survey for self-assessment of sweat rate and salt content prior to being informed 
of actual sweat rate and [NaCl]. The survey was comprised of five questions with 
answers indicated by subjects placing a vertical line along a horizontal visual analog 
scale line (Appendix item E). The relationship between predicted (self-assessed) and 
actual (measured) sweat [NaCl] and sweat rate was analyzed with Pearson product-
moment correlation (SPSS, ver. 17.0, Chicago, IL).   
No significant correlation was determined between self-assessed rate of sweating 
(question #1) and actual rate of sweating (r = 0.393, p = 0.119). There was also no 
significant correlation for answers to the first three questions related to saltiness of sweat 
(questions 2-4) with actual (measured) sweat [Na+] or [Cl-] (r = 0.149, and p = 0.567 for 
question # 2, r = 0.355, and p = 0.162 for question # 3, and r = 0.032, and p = 0.902 for 
question # 4. There was a significant correlation for answers to the last question on the 
survey (question #5, ‘how much salt do you think is in your sweat compared to others?’) 
and sweat [Na+] (r = 0.761, and p< 0.001). This indicates that factors other than ‘stinging 
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of sweat in the eyes’ and white salt residue on skin may have led subjects to correctly self 
–assess their sweat NaCl losses. However, before conclusions can be drawn from these 
correlations, additional population sampling will be needed to expand this dataset from 
its current limited size of n= 22 (16 males and 6 females) to include the additional 47 
healthy subjects for whom preliminary screening of sweat content was performed. An 
additional ~20 subjects should also be tested to balance gender and age groups. Future 
research should examine the predictability of other survey questions that may be useful to 
subjectively identify subjects with high versus low to normal sweat NaCl loss during 
exercise. If eventually determined to be effective, a survey such as this could be further 
developed into a testing tool for coaches, athletes, military personnel, and others that 
work with exercisers and laborers in the heat in order to identify those that may need to 
pay particular attention to electrolyte replacement during prolonged activity.  
 
4.9.  Summary of Future Directions 
Several potentially fruitful lines of investigation remain based on the primary 
dissertation work: 1) novel adaptation of two-photon microscopy to study inter-individual 
differences in ductal epithelial transport in living sweat glands of fresh skin biopsies; 2) 
quantifying expression of aquaporins in the human sweat duct and the relationship to 
[NaCl] of excreted sweat; 3) quantifying luminal HSD2 activity in the sweat duct of 
individuals with high sweat [Na+] and elevated basal plasma [AVP]; 4) quantifying 
colocalization of CFTR and ENaC in the sweat duct using laser confocal microscopy; 5) 
evaluating fluid and electrolyte balance during exercise in the heat with ad libitum vs. 
regimented fluid and/or electrolyte replacement and assessment of actual and predicted 
during- and post-exercise serum [Na+] for incidence and potential risk for exercise-
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induced hyponatremia; and 6) examining the predictability of survey questions that may 
be useful to subjectively identify individuals with high vs. normal sweat NaCl loss during 




PROTOCOL FOR CRYOSECTIONING AND IMMUNOSTAINING 
BIOPSIED HUMAN SKIN 
 
 Remove tissue to be cut from -80°C freezer and place in -20°C cryochamber to thaw 
for at least 30 min but optimally > 60 min prior to cutting.  
 Pour acetone methanol solution into coplin jar (1:1) and place in -20°C cryochamber 
for at least 30 min prior to use. 
 Begin gross sectioning at the surface of the epidermis, remove ~ 300 µm of tissue 
then cut a 6 μm sections and transfer to (any) slide. Let air dry at room temperature 
for at least 30 sec.  
 Apply a large droplet of hematoxylin to section.  
 After 2 min, rinse hematoxylin off slide carefully with light drizzle of distilled water 
or submerge very briefly in water.  
 View hematoxylin-stained section under light microscopy, 10-40x, to look for sweat 
ducts.  
 If an insufficient number of ductal cross sections are observed, then return to cutting. 
Remove only 90 to 150 µm of tissue each time during cutting before cutting another 6 
µm section to check for ducts with hematoxylin staining. 
 When a desired section is found under light microscopy (presence of sweat ducts), cut 
another 6 μm section and transfer to silane-coated slide 
 When three sections are on a silane-coated slide, place in acetone and methanol 
solution in coplin jar in cryochamber (-20° C) for 10 min. 
 Air dry slides at RT and put in slide holder, keep slide holder in cryochamber and 
keep lid on so that tissue debris during cutting does not land on slides.  
 When desired slides are prepared, perform immunostaining as soon as possible, 
keeping slides cold (cooler with ice packs) if transport is necessary.  
 Prepare PBS solution: use a 10x PBS prepared to 1x (so 100 ml of the 10x PBS + 900 
mL distilled water). Make two 1L bottles of this. 
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 Prepare permeabilization solution: 0.25% Triton in PBS for 10 min. For coplin jar 
size use 162.5 uL of Triton in 65 ml of PBS. For larger slide holder container, double 
that. Be sure to clip end off of pipet tip to make it easier. 
 Prepare blocking solution, the 1%BSA solution: 10ul of BSA serum+90 ul of PBS  
which is also 0.05g of dry BSA into 5 ml of PBS. 
 Submerge slides to rinsse in PBS solution in coplin jar for 2x3 min at room temp.  
 Permeabilization step: 0.25% Triton in PBS for 10 min 
 Submerge slides to rinse in PBS solution in coplin jar again, for 3x3 min at room 
temp. 
 Blocking in 1%BSA solution: Apply 100 ul per slide. Incubate 10-30 min at RT in 
humidifier box.  
 Prepare primary antibodies while blocking solution is on. But first decide which 
going to use together and make those up in the same vial. Dilutions are done with the 
1%BSA solution. Vortex vial(s) containing primary antibodies and 1%BSA for 3 sec, 
then keep on ice until used. 
o 1:10 CFTR M3A7 
o 1:200 αENaC 
o 1:500 Z01 
o 1:50 NaKATPase 
 After blocking step, just tip and firmly tap slide to clean surface to get excess off the 
serum. May also dab with a chemwipe to carefully dry around sections, this will keep 
antibody solutions from running all over the slide.  
 Apply primary antibody. Apply 80 μL per slide. Let sit in humidifier box sealed 
tightly at 4°C overnight.  
 Next day, tip and tap slides to get Ab excess off the slide, and do three times three 
minute soaks in PBS in coplin jar 
 Make up secondary antibodies: Alexa Fluor made up in 1:500 strength in PBS with 
1%BSA. Vortex mixture in vial for 3 sec. Keep away from light and on ice until use.  
 Apply secondary antibody, 100 μL per section, let sit in humidifier box sealed tightly  
for 1 hour at room temp in dark, then tip slides to get Ab excess off the slide. 
 Do three times three minute soaks in PBS in coplin jar 
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 Make up DAPI. The DAPI solution is made up for the coplin jar as 6 uL of the DAPI 
(already made up in vial in foil in fridge as 1 mg per ml) into 60 mL of PBS. Mix in 
flask and pour into coplin jar. Keep in dark. Soak in DAPI solution for 10 min in dark 
followed by 3x3 min rinses in PBS. Double this if making for the larger slide tray 
holder. OR, apply DAPI in Vecta Shield, apply per section about 1-2 drops, then 
carefully coverslip so get no air bubbles. Before coverslipping whether with or 
without DAPI in the coverslipping material, be sure to remove excess solution from 
front and back of slide with tissue carefully, particularly around the section itself.  
 Let dry in dark at least 90 min. Then can nailpolish sides, be carefully not to move 
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• Cycling at 50% aerobic capacity 
(VO2max) to 3% body mass loss


















SURVEY FOR SELF-ASSESSMENT OF SWEATING  
 
 
Name:_________________________         ID:_______       Date:________________  
        
This questionnaire asks about your current opinion regarding your own sweating.  
There are no right or wrong answers.  Please be as honest and accurate as possible in 
responses. Make a vertical line through each horizontal line below to indicate the 




1. How much do you sweat compared to others? 
 
Much, much more                                                        Much, much less 
                              _______________________________________________ 
  
 
             
2. Do you have stinging if sweat drips in your eyes? 
 
Very, very much                                                                      Not at all 
                              _______________________________________________ 
 
 
3. Do you have salt dried on your skin after sweating? 
 
Very, very much                                                   Not at all 
                               _______________________________________________ 
 
 
4. Do you have white salt stains on your clothing after sweating? 
 
Very, very much                                                                Not at all 
 
                              _______________________________________________ 
 
 
5.   How much salt do you think is in your sweat compared to others? 
 
Much, much more                                                        Much, much less 
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